{
	"donors": [
			{
				"submitter_donor_id": "DONOR_1",
				"program_id": "SYNTHETIC-2",
				"is_deceased": true,
				"cause_of_death": "Unknown",
				"date_of_birth": "1961-07",
				"date_of_death": "2009-07",
				"gender": "Woman",
				"sex_at_birth": "Unknown",
				"primary_site": [
					"Corpus uteri",
					"Anus and anal canal"
				],
				"primary_diagnoses": [
					{
						"submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_1",
						"date_of_diagnosis": "2019-06",
						"cancer_type_code": "C02.1",
						"basis_of_diagnosis": "Histology of a metastasis",
						"lymph_nodes_examined_status": "No lymph nodes found in resected specimen",
						"lymph_nodes_examined_method": "Lymph node dissection/pathological exam",
						"number_lymph_nodes_positive": 10,
						"clinical_tumour_staging_system": "FIGO staging system",
						"clinical_t_category": "TX",
						"clinical_n_category": "N1mi",
						"clinical_m_category": "M1a",
						"clinical_stage_group": "Stage IIIAES",
						"laterality": "Unilateral, side not specified",
						"specimens": [
							{
								"submitter_specimen_id": "SPECIMEN_1",
								"pathological_tumour_staging_system": "International Neuroblastoma Risk Group Staging System",
								"pathological_t_category": "T4a",
								"pathological_n_category": "N1",
								"pathological_m_category": "MX",
								"pathological_stage_group": "Stage IIAE",
								"specimen_collection_date": "2021-06-01",
								"specimen_storage": "Frozen in liquid nitrogen",
								"tumour_histological_type": "8820/3",
								"specimen_anatomic_location": "C67.6",
								"reference_pathology_confirmed_diagnosis": "Not done",
								"reference_pathology_confirmed_tumour_presence": "Unknown",
								"tumour_grading_system": "Grading system for GISTs",
								"tumour_grade": "Grade 3",
								"percent_tumour_cells_range": "0-19%",
								"percent_tumour_cells_measurement_method": "Pathology estimate by percent nuclei",
								"specimen_processing": "Cryopreservation in liquid nitrogen (dead tissue)",
								"specimen_laterality": "Right",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_1",
										"specimen_tissue_source": "Pleural fluid",
										"tumour_normal_designation": "Tumour",
										"specimen_type": "Cell line - derived from normal",
										"sample_type": "Other DNA enrichments"
									},
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_2",
										"specimen_tissue_source": "Seminal fluid",
										"tumour_normal_designation": "Tumour",
										"specimen_type": "Xenograft - derived from metastatic tumour",
										"sample_type": "rRNA-depleted RNA"
									},
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_3",
										"specimen_tissue_source": "Seminal fluid",
										"tumour_normal_designation": "Tumour",
										"specimen_type": "Primary tumour",
										"sample_type": "Protein"
									}
								],
								"biomarkers": [
									{
										"er_status": "Cannot be determined",
										"pr_status": "Not applicable",
										"her2_ihc_status": "Equivocal",
										"her2_ish_status": "Unknown",
										"hpv_ihc_status": "Not applicable",
										"hpv_pcr_status": "Unknown",
										"hpv_strain": [
											"HPV68"
										],
										"test_interval": 7,
										"psa_level": 343,
										"ca125": 58,
										"cea": 9,
										"er_percent_positive": 19.1,
										"pr_percent_positive": 17.9
									},
									{
										"er_status": "Unknown",
										"pr_status": "Not applicable",
										"her2_ihc_status": "Equivocal",
										"her2_ish_status": "Positive",
										"hpv_ihc_status": "Not applicable",
										"hpv_pcr_status": "Negative",
										"hpv_strain": [
											"HPV18"
										],
										"test_interval": 6,
										"psa_level": 399,
										"ca125": 73,
										"cea": 8,
										"er_percent_positive": 45.5,
										"pr_percent_positive": 52.5
									}
								]
							},
							{
								"submitter_specimen_id": "SPECIMEN_2",
								"pathological_tumour_staging_system": "AJCC 7th edition",
								"pathological_t_category": "T4a",
								"pathological_n_category": "N2a",
								"pathological_m_category": "M1d",
								"pathological_stage_group": "Stage IIIC2",
								"specimen_collection_date": "2020-06-30",
								"specimen_storage": "Not Applicable",
								"tumour_histological_type": "8980/2",
								"specimen_anatomic_location": "C43.9",
								"reference_pathology_confirmed_diagnosis": "No",
								"reference_pathology_confirmed_tumour_presence": "Unknown",
								"tumour_grading_system": "IASLC grading system",
								"tumour_grade": "Grade Group 5",
								"percent_tumour_cells_range": "20-50%",
								"percent_tumour_cells_measurement_method": "Unknown",
								"specimen_processing": "Fresh",
								"specimen_laterality": "Not applicable",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_4",
										"specimen_tissue_source": "Hydrocele fluid",
										"tumour_normal_designation": "Tumour",
										"specimen_type": "Normal",
										"sample_type": "Other DNA enrichments"
									},
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_5",
										"specimen_tissue_source": "Sputum",
										"tumour_normal_designation": "Tumour",
										"specimen_type": "Normal",
										"sample_type": "Total RNA"
									},
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_6",
										"specimen_tissue_source": "Cervical mucus",
										"tumour_normal_designation": "Tumour",
										"specimen_type": "Recurrent tumour",
										"sample_type": "Total DNA"
									}
								],
								"biomarkers": []
							},
							{
								"submitter_specimen_id": "SPECIMEN_3",
								"pathological_tumour_staging_system": "AJCC 7th edition",
								"pathological_t_category": "T1a2",
								"pathological_n_category": "N2c",
								"pathological_m_category": "M1a(1)",
								"pathological_stage_group": "Stage IIBE",
								"specimen_collection_date": "2020-10-26",
								"specimen_storage": "Frozen in vapour phase",
								"tumour_histological_type": "8209/3",
								"specimen_anatomic_location": "C43.9",
								"reference_pathology_confirmed_diagnosis": "Not done",
								"reference_pathology_confirmed_tumour_presence": "Yes",
								"tumour_grading_system": "Nuclear grading system for DCIS",
								"tumour_grade": "G3",
								"percent_tumour_cells_range": "51-100%",
								"percent_tumour_cells_measurement_method": "Image analysis",
								"specimen_processing": "Formalin fixed - unbuffered",
								"specimen_laterality": "Left",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_7",
										"specimen_tissue_source": "Vitreous fluid",
										"tumour_normal_designation": "Tumour",
										"specimen_type": "Metastatic tumour - metastasis to distant location",
										"sample_type": "polyA+ RNA"
									},
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_8",
										"specimen_tissue_source": "Seminal fluid",
										"tumour_normal_designation": "Normal",
										"specimen_type": "Normal - tissue adjacent to primary tumour",
										"sample_type": "Total DNA"
									}
								],
								"biomarkers": []
							}
						],
						"treatments": [
							{
								"submitter_treatment_id": "TREATMENT_1",
								"is_primary_treatment": "Unknown",
								"treatment_start_date": "2021-01",
								"treatment_end_date": "2022-08",
								"treatment_setting": "Mobilization",
								"treatment_intent": "Screening",
								"days_per_cycle": 4,
								"number_of_cycles": 5,
								"line_of_treatment": 5,
								"status_of_treatment": "Other",
								"treatment_type": [
									"Bone marrow transplant",
									"Photodynamic therapy"
								],
								"response_to_treatment_criteria_method": "Response Assessment in Neuro-Oncology (RANO)",
								"response_to_treatment": "Complete response",
								"chemotherapies": [
									{
										"chemotherapy_drug_dose_units": "ug/m2",
										"drug_reference_database": "NCI Thesaurus",
										"drug_name": "LEUCOVORIN",
										"drug_reference_identifier": "876459",
										"prescribed_cumulative_drug_dose": 4600,
										"actual_cumulative_drug_dose": 66
									},
									{
										"chemotherapy_drug_dose_units": "ug/m2",
										"drug_reference_database": "PubChem",
										"drug_name": "FLUOROURACIL",
										"drug_reference_identifier": "87354",
										"prescribed_cumulative_drug_dose": 150,
										"actual_cumulative_drug_dose": 94
									},
									{
										"chemotherapy_drug_dose_units": "mg/m2",
										"drug_reference_database": "PubChem",
										"drug_name": "LIPOSOMAL IRINOTECAN",
										"drug_reference_identifier": "7365837",
										"prescribed_cumulative_drug_dose": 320,
										"actual_cumulative_drug_dose": 60
									}
								],
								"hormone_therapies": [],
								"immunotherapies": [],

								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_1",
										"date_of_followup": "2022-08",
										"disease_status_at_followup": "Loco-regional progression",
										"relapse_type": "Distant recurrence/metastasis",
										"date_of_relapse": "2022-01",
										"method_of_progression_status": [],
										"anatomic_site_progression_or_recurrence": "C06",
										"recurrence_tumour_staging_system": "SEER staging system",
										"recurrence_t_category": "T2(m)",
										"recurrence_n_category": "N2c",
										"recurrence_m_category": "M1b(1)",
										"recurrence_stage_group": "Stage IIBES",
										"biomarkers": [
											{
												"er_status": "Negative",
												"pr_status": "Unknown",
												"her2_ihc_status": "Negative",
												"her2_ish_status": "Equivocal",
												"hpv_ihc_status": "Negative",
												"hpv_pcr_status": "Positive",
												"hpv_strain": [
													"HPV31",
													"HPV68"
												],
												"test_interval": 5,
												"psa_level": 318,
												"ca125": 78,
												"cea": 13,
												"er_percent_positive": 12.4,
												"pr_percent_positive": 11.0
											},
											{
												"er_status": "Cannot be determined",
												"pr_status": "Unknown",
												"her2_ihc_status": "Equivocal",
												"her2_ish_status": "Negative",
												"hpv_ihc_status": "Not applicable",
												"hpv_pcr_status": "Negative",
												"hpv_strain": [
													"HPV35"
												],
												"test_interval": 4,
												"psa_level": 379,
												"ca125": 106,
												"cea": 4,
												"er_percent_positive": 18.3,
												"pr_percent_positive": 65.2
											},
											{
												"er_status": "Cannot be determined",
												"pr_status": "Not applicable",
												"her2_ihc_status": "Not applicable",
												"her2_ish_status": "Cannot be determined",
												"hpv_ihc_status": "Cannot be determined",
												"hpv_pcr_status": "Unknown",
												"hpv_strain": [
													"HPV18"
												],
												"test_interval": 8,
												"psa_level": 328,
												"ca125": 104,
												"cea": 13,
												"er_percent_positive": 21.0,
												"pr_percent_positive": 32.7
											}
										]
									},
									{
										"submitter_follow_up_id": "FOLLOW_UP_2",
										"date_of_followup": "2022-11",
										"disease_status_at_followup": "Loco-regional progression",
										"relapse_type": "Biochemical progression",
										"date_of_relapse": "2022-05",
										"method_of_progression_status": [
											"Imaging (procedure)",
											"Laboratory data interpretation (procedure)"
										],
										"anatomic_site_progression_or_recurrence": "C05",
										"recurrence_tumour_staging_system": "Lugano staging system",
										"recurrence_t_category": "T1d",
										"recurrence_n_category": "N1mi",
										"recurrence_m_category": "M1a(0)",
										"recurrence_stage_group": "Stage IVBS",
										"biomarkers": [
											{
												"er_status": "Positive",
												"pr_status": "Positive",
												"her2_ihc_status": "Not applicable",
												"her2_ish_status": "Equivocal",
												"hpv_ihc_status": "Unknown",
												"hpv_pcr_status": "Not applicable",
												"hpv_strain": [
													"HPV73"
												],
												"test_interval": 5,
												"psa_level": 351,
												"ca125": 81,
												"cea": 7,
												"er_percent_positive": 97.8,
												"pr_percent_positive": 32.9
											},
											{
												"er_status": "Not applicable",
												"pr_status": "Cannot be determined",
												"her2_ihc_status": "Positive",
												"her2_ish_status": "Unknown",
												"hpv_ihc_status": "Cannot be determined",
												"hpv_pcr_status": "Positive",
												"hpv_strain": [
													"HPV68"
												],
												"test_interval": 8,
												"psa_level": 326,
												"ca125": 96,
												"cea": 11,
												"er_percent_positive": 13.7,
												"pr_percent_positive": 85.4
											},
											{
												"er_status": "Unknown",
												"pr_status": "Not applicable",
												"her2_ihc_status": "Equivocal",
												"her2_ish_status": "Unknown",
												"hpv_ihc_status": "Negative",
												"hpv_pcr_status": "Unknown",
												"hpv_strain": [
													"HPV68",
													"HPV18"
												],
												"test_interval": 7,
												"psa_level": 212,
												"ca125": 54,
												"cea": 8,
												"er_percent_positive": 5.3,
												"pr_percent_positive": 74.3
											}
										]
									},
									{
										"submitter_follow_up_id": "FOLLOW_UP_3",
										"date_of_followup": "2022-10",
										"disease_status_at_followup": "No evidence of disease",
										"relapse_type": "Local recurrence and distant metastasis",
										"date_of_relapse": "2022-07",
										"method_of_progression_status": [
											"Histopathology test (procedure)",
											"Assessment of symptom control (procedure)"
										],
										"anatomic_site_progression_or_recurrence": "C18",
										"recurrence_tumour_staging_system": "International Neuroblastoma Risk Group Staging System",
										"recurrence_t_category": "T1b2",
										"recurrence_n_category": "N1b",
										"recurrence_m_category": "M0",
										"recurrence_stage_group": "Stage IIEA",
										"biomarkers": []
									}
								],
								"biomarkers": [
									{
										"er_status": "Cannot be determined",
										"pr_status": "Not applicable",
										"her2_ihc_status": "Equivocal",
										"her2_ish_status": "Unknown",
										"hpv_ihc_status": "Not applicable",
										"hpv_pcr_status": "Unknown",
										"hpv_strain": [
											"HPV68"
										],
										"test_interval": 7,
										"psa_level": 343,
										"ca125": 58,
										"cea": 9,
										"er_percent_positive": 19.1,
										"pr_percent_positive": 17.9
									},
									{
										"er_status": "Unknown",
										"pr_status": "Not applicable",
										"her2_ihc_status": "Equivocal",
										"her2_ish_status": "Positive",
										"hpv_ihc_status": "Not applicable",
										"hpv_pcr_status": "Negative",
										"hpv_strain": [
											"HPV18"
										],
										"test_interval": 6,
										"psa_level": 399,
										"ca125": 73,
										"cea": 8,
										"er_percent_positive": 45.5,
										"pr_percent_positive": 52.5
									}
								]
							},
							{
								"submitter_treatment_id": "TREATMENT_2",
								"is_primary_treatment": "Yes",
								"treatment_start_date": "2021-12",
								"treatment_end_date": "2022-10",
								"treatment_setting": "Conditioning",
								"treatment_intent": "Palliative",
								"days_per_cycle": 4,
								"number_of_cycles": 3,
								"line_of_treatment": 3,
								"status_of_treatment": "Treatment stopped due to acute toxicity",
								"treatment_type": [
									"Radiation therapy",
									"Other targeting molecular therapy",
									"Hormonal therapy"
								],
								"response_to_treatment_criteria_method": "Cheson CLL 2012 Oncology Response Criteria",
								"response_to_treatment": "Major response",
								"chemotherapies": [
									{
										"chemotherapy_drug_dose_units": "IU/kg",
										"drug_reference_database": "PubChem",
										"drug_name": "NIVOLUMAB",
										"drug_reference_identifier": "7365837",
										"prescribed_cumulative_drug_dose": 150,
										"actual_cumulative_drug_dose": 111
									},
									{
										"chemotherapy_drug_dose_units": "mg/m2",
										"drug_reference_database": "NCI Thesaurus",
										"drug_name": "FLUOROURACIL",
										"drug_reference_identifier": "836754",
										"prescribed_cumulative_drug_dose": 4600,
										"actual_cumulative_drug_dose": 90
									}
								],
								"hormone_therapies": [],
								"immunotherapies": [],

								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_4",
										"date_of_followup": "2022-11",
										"disease_status_at_followup": "Distant progression",
										"relapse_type": "Progression (liquid tumours)",
										"date_of_relapse": "2021-12",
										"method_of_progression_status": [
											"Tumor marker measurement (procedure)",
											"Physical examination procedure (procedure)"
										],
										"anatomic_site_progression_or_recurrence": "C10",
										"recurrence_tumour_staging_system": "Rai staging system",
										"recurrence_t_category": "T2b",
										"recurrence_n_category": "N2mi",
										"recurrence_m_category": "M1d",
										"recurrence_stage_group": "Stage IIIS",
										"biomarkers": []
									},
									{
										"submitter_follow_up_id": "FOLLOW_UP_5",
										"date_of_followup": "2022-11",
										"disease_status_at_followup": "Distant progression",
										"relapse_type": "Progression (liquid tumours)",
										"date_of_relapse": "2022-05",
										"method_of_progression_status": [],
										"anatomic_site_progression_or_recurrence": "C08",
										"recurrence_tumour_staging_system": "AJCC 6th edition",
										"recurrence_t_category": "T2a1",
										"recurrence_n_category": "N0b",
										"recurrence_m_category": "M1e",
										"recurrence_stage_group": "Stage IIB",
										"biomarkers": []
									},
									{
										"submitter_follow_up_id": "FOLLOW_UP_6",
										"date_of_followup": "2022-08",
										"disease_status_at_followup": "No evidence of disease",
										"relapse_type": "Local recurrence and distant metastasis",
										"date_of_relapse": "2022-10",
										"method_of_progression_status": [],
										"anatomic_site_progression_or_recurrence": "C13",
										"recurrence_tumour_staging_system": "Revised International staging system (RISS)",
										"recurrence_t_category": "T2(m)",
										"recurrence_n_category": "N1a",
										"recurrence_m_category": "M1",
										"recurrence_stage_group": "Stage 0is",
										"biomarkers": []
									}
								],
								"biomarkers": [
									{
										"er_status": "Positive",
										"pr_status": "Unknown",
										"her2_ihc_status": "Cannot be determined",
										"her2_ish_status": "Not applicable",
										"hpv_ihc_status": "Not applicable",
										"hpv_pcr_status": "Negative",
										"hpv_strain": [
											"HPV51"
										],
										"test_interval": 7,
										"psa_level": 207,
										"ca125": 112,
										"cea": 9,
										"er_percent_positive": 73.5,
										"pr_percent_positive": 72.8
									},
									{
										"er_status": "Positive",
										"pr_status": "Not applicable",
										"her2_ihc_status": "Unknown",
										"her2_ish_status": "Equivocal",
										"hpv_ihc_status": "Not applicable",
										"hpv_pcr_status": "Cannot be determined",
										"hpv_strain": [
											"HPV33"
										],
										"test_interval": 7,
										"psa_level": 327,
										"ca125": 103,
										"cea": 8,
										"er_percent_positive": 65.8,
										"pr_percent_positive": 23.6
									}
								]
							},
							{
								"submitter_treatment_id": "TREATMENT_3",
								"is_primary_treatment": "Yes",
								"treatment_start_date": "2021-09",
								"treatment_end_date": "2022-10",
								"treatment_setting": "Maintenance",
								"treatment_intent": "Palliative",
								"days_per_cycle": 4,
								"number_of_cycles": 4,
								"line_of_treatment": 3,
								"status_of_treatment": "Physician decision (stopped or interrupted treatment)",
								"treatment_type": [
									"Bone marrow transplant",
									"Other targeting molecular therapy",
									"Radiation therapy"
								],
								"response_to_treatment_criteria_method": "iRECIST",
								"response_to_treatment": "Morphologic leukemia-free state",
								"chemotherapies": [
									{
										"chemotherapy_drug_dose_units": "mg/m2",
										"drug_reference_database": "PubChem",
										"drug_name": "GEMCITABINE",
										"drug_reference_identifier": "836754",
										"prescribed_cumulative_drug_dose": 780,
										"actual_cumulative_drug_dose": 78
									}
								],
								"hormone_therapies": [],
								"immunotherapies": [],

								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_7",
										"date_of_followup": "2022-10",
										"disease_status_at_followup": "No evidence of disease",
										"relapse_type": "Biochemical progression",
										"date_of_relapse": "2022-08",
										"method_of_progression_status": [
											"Laboratory data interpretation (procedure)"
										],
										"anatomic_site_progression_or_recurrence": "C12",
										"recurrence_tumour_staging_system": "St Jude staging system",
										"recurrence_t_category": "Tis pu",
										"recurrence_n_category": "N1a(sn)",
										"recurrence_m_category": "M1a(0)",
										"recurrence_stage_group": "Stage IAB",
										"biomarkers": []
									},
									{
										"submitter_follow_up_id": "FOLLOW_UP_8",
										"date_of_followup": "2022-11",
										"disease_status_at_followup": "Distant progression",
										"relapse_type": "Progression (liquid tumours)",
										"date_of_relapse": "2022-03",
										"method_of_progression_status": [],
										"anatomic_site_progression_or_recurrence": "C01",
										"recurrence_tumour_staging_system": "SEER staging system",
										"recurrence_t_category": "T1",
										"recurrence_n_category": "N1b",
										"recurrence_m_category": "M1b(1)",
										"recurrence_stage_group": "Stage L1",
										"biomarkers": []
									}
								],
								"biomarkers": []
							}
						],
						"biomarkers": [],
						"followups": []
					},
					{
						"submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_2",
						"date_of_diagnosis": "2019-03",
						"cancer_type_code": "C02.2",
						"basis_of_diagnosis": "Clinical investigation",
						"lymph_nodes_examined_status": "Not applicable",
						"lymph_nodes_examined_method": "Physical palpation of patient",
						"number_lymph_nodes_positive": 5,
						"clinical_tumour_staging_system": "International Neuroblastoma Staging System",
						"clinical_t_category": "T1b",
						"clinical_n_category": "N2",
						"clinical_m_category": "M1d(1)",
						"clinical_stage_group": "Stage Ms",
						"laterality": "Left",
						"specimens": [
							{
								"submitter_specimen_id": "SPECIMEN_4",
								"pathological_tumour_staging_system": "SEER staging system",
								"pathological_t_category": "T2a2",
								"pathological_n_category": "N0(i+)",
								"pathological_m_category": "M1b",
								"pathological_stage_group": "Stage IAS",
								"specimen_collection_date": "2021-05-10",
								"specimen_storage": "Unknown",
								"tumour_histological_type": "8980/9",
								"specimen_anatomic_location": "C43.9",
								"reference_pathology_confirmed_diagnosis": "Yes",
								"reference_pathology_confirmed_tumour_presence": "Not done",
								"tumour_grading_system": "Grading system for GISTs",
								"tumour_grade": "Low",
								"percent_tumour_cells_range": "0-19%",
								"percent_tumour_cells_measurement_method": "Unknown",
								"specimen_processing": "Cryopreservation of live cells in liquid nitrogen",
								"specimen_laterality": "Right",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_10",
										"specimen_tissue_source": "Pleural fluid",
										"tumour_normal_designation": "Normal",
										"specimen_type": "Metastatic tumour - metastasis local to lymph node",
										"sample_type": "Total DNA"
									},
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_9",
										"specimen_tissue_source": "Buffy coat",
										"tumour_normal_designation": "Normal",
										"specimen_type": "Metastatic tumour - metastasis to distant location",
										"sample_type": "rRNA-depleted RNA"
									}
								],
								"biomarkers": []
							},
							{
								"submitter_specimen_id": "SPECIMEN_5",
								"pathological_tumour_staging_system": "AJCC 6th edition",
								"pathological_t_category": "Tis(DCIS)",
								"pathological_n_category": "N0a",
								"pathological_m_category": "M1c",
								"pathological_stage_group": "Stage II bulky",
								"specimen_collection_date": "2021-02-13",
								"specimen_storage": "Unknown",
								"tumour_histological_type": "8620/9",
								"specimen_anatomic_location": "C34.9",
								"reference_pathology_confirmed_diagnosis": "No",
								"reference_pathology_confirmed_tumour_presence": "Yes",
								"tumour_grading_system": "Gleason grade group system",
								"tumour_grade": "Grade Group 5",
								"percent_tumour_cells_range": "20-50%",
								"percent_tumour_cells_measurement_method": "Image analysis",
								"specimen_processing": "Cryopreservation in dry ice (dead tissue)",
								"specimen_laterality": "Not applicable",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_11",
										"specimen_tissue_source": "Buffy coat",
										"tumour_normal_designation": "Tumour",
										"specimen_type": "Normal - tissue adjacent to primary tumour",
										"sample_type": "polyA+ RNA"
									}
								],
								"biomarkers": []
							},
							{
								"submitter_specimen_id": "SPECIMEN_6",
								"pathological_tumour_staging_system": "AJCC 7th edition",
								"pathological_t_category": "T3e",
								"pathological_n_category": "N3a",
								"pathological_m_category": "M1",
								"pathological_stage_group": "Stage IVAS",
								"specimen_collection_date": "2020-10-18",
								"specimen_storage": "RNA later frozen",
								"tumour_histological_type": "8620/9",
								"specimen_anatomic_location": "C67.6",
								"reference_pathology_confirmed_diagnosis": "Yes",
								"reference_pathology_confirmed_tumour_presence": "No",
								"tumour_grading_system": "Four-tier grading system",
								"tumour_grade": "Grade 4",
								"percent_tumour_cells_range": "51-100%",
								"percent_tumour_cells_measurement_method": "Pathology estimate by percent nuclei",
								"specimen_processing": "Cryopreservation in dry ice (dead tissue)",
								"specimen_laterality": "Unknown",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_12",
										"specimen_tissue_source": "Amniotic fluid",
										"tumour_normal_designation": "Tumour",
										"specimen_type": "Primary tumour - additional new primary",
										"sample_type": "Protein"
									}
								],
								"biomarkers": []
							}
						],
						"treatments": [
							{
								"submitter_treatment_id": "TREATMENT_4",
								"is_primary_treatment": "No",
								"treatment_start_date": "2021-09",
								"treatment_end_date": "2022-09",
								"treatment_setting": "Radiosensitization",
								"treatment_intent": "Guidance",
								"days_per_cycle": 4,
								"number_of_cycles": 5,
								"line_of_treatment": 5,
								"status_of_treatment": "Physician decision (stopped or interrupted treatment)",
								"treatment_type": [
									"Surgery",
									"Radiation therapy"
								],
								"response_to_treatment_criteria_method": "Response Assessment in Neuro-Oncology (RANO)",
								"response_to_treatment": "Physician assessed partial response",
								"chemotherapies": [
									{
										"chemotherapy_drug_dose_units": "mg/m2",
										"drug_reference_database": "PubChem",
										"drug_name": "NIVOLUMAB",
										"drug_reference_identifier": "87354",
										"prescribed_cumulative_drug_dose": 150,
										"actual_cumulative_drug_dose": 111
									}
								],
								"hormone_therapies": [],
								"immunotherapies": [],

								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_10",
										"date_of_followup": "2022-08",
										"disease_status_at_followup": "Distant progression",
										"relapse_type": "Local recurrence and distant metastasis",
										"date_of_relapse": "2022-08",
										"method_of_progression_status": [],
										"anatomic_site_progression_or_recurrence": "C01",
										"recurrence_tumour_staging_system": "Binet staging system",
										"recurrence_t_category": "T1a(s)",
										"recurrence_n_category": "N4",
										"recurrence_m_category": "M0(i+)",
										"recurrence_stage_group": "Stage IE",
										"biomarkers": []
									},
									{
										"submitter_follow_up_id": "FOLLOW_UP_9",
										"date_of_followup": "2022-11",
										"disease_status_at_followup": "Distant progression",
										"relapse_type": "Progression (liquid tumours)",
										"date_of_relapse": "2022-08",
										"method_of_progression_status": [],
										"anatomic_site_progression_or_recurrence": "C10",
										"recurrence_tumour_staging_system": "Revised International staging system (RISS)",
										"recurrence_t_category": "T2b",
										"recurrence_n_category": "N2c",
										"recurrence_m_category": "MX",
										"recurrence_stage_group": "Stage IBS",
										"biomarkers": []
									}
								],
								"biomarkers": []
							},
							{
								"submitter_treatment_id": "TREATMENT_5",
								"is_primary_treatment": "No",
								"treatment_start_date": "2021-05",
								"treatment_end_date": "2022-05",
								"treatment_setting": "Conditioning",
								"treatment_intent": "Curative",
								"days_per_cycle": 5,
								"number_of_cycles": 5,
								"line_of_treatment": 1,
								"status_of_treatment": "Treatment stopped due to acute toxicity",
								"treatment_type": [
									"Surgery",
									"Radiation therapy"
								],
								"response_to_treatment_criteria_method": "Response Assessment in Neuro-Oncology (RANO)",
								"response_to_treatment": "Stable disease",
								"chemotherapies": [],
								"hormone_therapies": [
									{
										"hormone_drug_dose_units": "IU/kg",
										"drug_reference_database": "RxNorm",
										"drug_name": "leuprolide",
										"drug_reference_identifier": "258494",
										"prescribed_cumulative_drug_dose": 160,
										"actual_cumulative_drug_dose": 73
									},
									{
										"hormone_drug_dose_units": "mg/m2",
										"drug_reference_database": "PubChem",
										"drug_name": "degarelix",
										"drug_reference_identifier": "258494",
										"prescribed_cumulative_drug_dose": 106,
										"actual_cumulative_drug_dose": 114
									},
									{
										"hormone_drug_dose_units": "ug/m2",
										"drug_reference_database": "PubChem",
										"drug_name": "degarelix",
										"drug_reference_identifier": "46475",
										"prescribed_cumulative_drug_dose": 179,
										"actual_cumulative_drug_dose": 97
									}
								],
								"immunotherapies": [],

								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_11",
										"date_of_followup": "2022-10",
										"disease_status_at_followup": "Relapse or recurrence",
										"relapse_type": "Local recurrence and distant metastasis",
										"date_of_relapse": "2022-02",
										"method_of_progression_status": [],
										"anatomic_site_progression_or_recurrence": "C13",
										"recurrence_tumour_staging_system": "Revised International staging system (RISS)",
										"recurrence_t_category": "T4a(s)",
										"recurrence_n_category": "N4",
										"recurrence_m_category": "M1b",
										"recurrence_stage_group": "Stage IVA",
										"biomarkers": []
									}
								],
								"biomarkers": []
							},
							{
								"submitter_treatment_id": "TREATMENT_6",
								"is_primary_treatment": "Unknown",
								"treatment_start_date": "2021-04",
								"treatment_end_date": "2022-10",
								"treatment_setting": "Neoadjuvant",
								"treatment_intent": "Guidance",
								"days_per_cycle": 3,
								"number_of_cycles": 3,
								"line_of_treatment": 1,
								"status_of_treatment": "Unknown",
								"treatment_type": [
									"Radiation therapy",
									"Surgery"
								],
								"response_to_treatment_criteria_method": "Response Assessment in Neuro-Oncology (RANO)",
								"response_to_treatment": "Immune partial response (iPR)",
								"chemotherapies": [],
								"hormone_therapies": [
									{
										"hormone_drug_dose_units": "IU/m2",
										"drug_reference_database": "PubChem",
										"drug_name": "leuprolide",
										"drug_reference_identifier": "258494",
										"prescribed_cumulative_drug_dose": 71,
										"actual_cumulative_drug_dose": 92
									},
									{
										"hormone_drug_dose_units": "g/m2",
										"drug_reference_database": "NCI Thesaurus",
										"drug_name": "triptorelin",
										"drug_reference_identifier": "258494",
										"prescribed_cumulative_drug_dose": 76,
										"actual_cumulative_drug_dose": 156
									}
								],
								"immunotherapies": [],

								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_12",
										"date_of_followup": "2022-08",
										"disease_status_at_followup": "Stable",
										"relapse_type": "Local recurrence",
										"date_of_relapse": "2022-05",
										"method_of_progression_status": [
											"Physical examination procedure (procedure)"
										],
										"anatomic_site_progression_or_recurrence": "C06",
										"recurrence_tumour_staging_system": "Rai staging system",
										"recurrence_t_category": "T3e",
										"recurrence_n_category": "N1b",
										"recurrence_m_category": "M1c",
										"recurrence_stage_group": "Stage A",
										"biomarkers": []
									}
								],
								"biomarkers": []
							}
						],
						"biomarkers": [],
						"followups": []
					},
					{
						"submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_3",
						"date_of_diagnosis": "2019-09",
						"cancer_type_code": "C64.9",
						"basis_of_diagnosis": "Clinical investigation",
						"lymph_nodes_examined_status": "No lymph nodes found in resected specimen",
						"lymph_nodes_examined_method": "Lymph node dissection/pathological exam",
						"number_lymph_nodes_positive": 9,
						"clinical_tumour_staging_system": "FIGO staging system",
						"clinical_t_category": "T1d",
						"clinical_n_category": "N1a(sn)",
						"clinical_m_category": "M0(i+)",
						"clinical_stage_group": "Stage IIE",
						"laterality": "Left",
						"specimens": [
							{
								"submitter_specimen_id": "SPECIMEN_7",
								"pathological_tumour_staging_system": "AJCC 6th edition",
								"pathological_t_category": "Tis(LCIS)",
								"pathological_n_category": "N2b",
								"pathological_m_category": "M1a(0)",
								"pathological_stage_group": "Stage L1",
								"specimen_collection_date": "2020-10-19",
								"specimen_storage": "Frozen in -70 freezer",
								"tumour_histological_type": "8830/6",
								"specimen_anatomic_location": "C50.9",
								"reference_pathology_confirmed_diagnosis": "Unknown",
								"reference_pathology_confirmed_tumour_presence": "Not done",
								"tumour_grading_system": "Four-tier grading system",
								"tumour_grade": "G4",
								"percent_tumour_cells_range": "0-19%",
								"percent_tumour_cells_measurement_method": "Pathology estimate by percent nuclei",
								"specimen_processing": "Cryopreservation of live cells in liquid nitrogen",
								"specimen_laterality": "Unknown",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_13",
										"specimen_tissue_source": "Saliva",
										"tumour_normal_designation": "Normal",
										"specimen_type": "Recurrent tumour",
										"sample_type": "ctDNA"
									}
								],
								"biomarkers": []
							},
							{
								"submitter_specimen_id": "SPECIMEN_8",
								"pathological_tumour_staging_system": "Lugano staging system",
								"pathological_t_category": "T4e",
								"pathological_n_category": "N1b",
								"pathological_m_category": "M1d",
								"pathological_stage_group": "Stage IS",
								"specimen_collection_date": "2020-02-29",
								"specimen_storage": "Cut slide",
								"tumour_histological_type": "8962/1",
								"specimen_anatomic_location": "C43.1",
								"reference_pathology_confirmed_diagnosis": "Not done",
								"reference_pathology_confirmed_tumour_presence": "Not done",
								"tumour_grading_system": "Grading system for GISTs",
								"tumour_grade": "GX",
								"percent_tumour_cells_range": "0-19%",
								"percent_tumour_cells_measurement_method": "Pathology estimate by percent nuclei",
								"specimen_processing": "Cryopreservation in dry ice (dead tissue)",
								"specimen_laterality": "Left",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_14",
										"specimen_tissue_source": "Urine",
										"tumour_normal_designation": "Normal",
										"specimen_type": "Xenograft - derived from metastatic tumour",
										"sample_type": "Total RNA"
									}
								],
								"biomarkers": []
							}
						],
						"treatments": [
							{
								"submitter_treatment_id": "TREATMENT_7",
								"is_primary_treatment": "No",
								"treatment_start_date": "2021-04",
								"treatment_end_date": "2022-03",
								"treatment_setting": "Mobilization",
								"treatment_intent": "Curative",
								"days_per_cycle": 3,
								"number_of_cycles": 5,
								"line_of_treatment": 3,
								"status_of_treatment": "Other",
								"treatment_type": [
									"Chemotherapy",
									"Hormonal therapy"
								],
								"response_to_treatment_criteria_method": "iRECIST",
								"response_to_treatment": "Immune complete response (iCR)",
								"chemotherapies": [],
								"hormone_therapies": [
									{
										"hormone_drug_dose_units": "g/m2",
										"drug_reference_database": "PubChem",
										"drug_name": "goserelin",
										"drug_reference_identifier": "557845",
										"prescribed_cumulative_drug_dose": 187,
										"actual_cumulative_drug_dose": 133
									}
								],
								"immunotherapies": [],

								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_13",
										"date_of_followup": "2022-10",
										"disease_status_at_followup": "Stable",
										"relapse_type": "Progression (liquid tumours)",
										"date_of_relapse": "2021-12",
										"method_of_progression_status": [],
										"anatomic_site_progression_or_recurrence": "C09",
										"recurrence_tumour_staging_system": "AJCC 7th edition",
										"recurrence_t_category": "T1b(s)",
										"recurrence_n_category": "N1a(sn)",
										"recurrence_m_category": "M1b(1)",
										"recurrence_stage_group": "Stage IAB",
										"biomarkers": []
									}
								],
								"biomarkers": []
							},
							{
								"submitter_treatment_id": "TREATMENT_8",
								"is_primary_treatment": "Unknown",
								"treatment_start_date": "2021-08",
								"treatment_end_date": "2022-01",
								"treatment_setting": "Induction",
								"treatment_intent": "Palliative",
								"days_per_cycle": 3,
								"number_of_cycles": 5,
								"line_of_treatment": 1,
								"status_of_treatment": "Unknown",
								"treatment_type": [
									"Hormonal therapy"
								],
								"response_to_treatment_criteria_method": "RECIST 1.1",
								"response_to_treatment": "Immune confirmed progressive disease (iCPD)",
								"chemotherapies": [],
								"hormone_therapies": [
									{
										"hormone_drug_dose_units": "IU/m2",
										"drug_reference_database": "RxNorm",
										"drug_name": "exemestane",
										"drug_reference_identifier": "223986",
										"prescribed_cumulative_drug_dose": 124,
										"actual_cumulative_drug_dose": 134
									}
								],
								"immunotherapies": [],

								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_14",
										"date_of_followup": "2022-11",
										"disease_status_at_followup": "Relapse or recurrence",
										"relapse_type": "Biochemical progression",
										"date_of_relapse": "2022-02",
										"method_of_progression_status": [
											"Assessment of symptom control (procedure)"
										],
										"anatomic_site_progression_or_recurrence": "C03",
										"recurrence_tumour_staging_system": "AJCC 6th edition",
										"recurrence_t_category": "T3d",
										"recurrence_n_category": "N2a",
										"recurrence_m_category": "M1b",
										"recurrence_stage_group": "Stage IS",
										"biomarkers": []
									}
								],
								"biomarkers": []
							}
						],
						"biomarkers": [],
						"followups": []
					}
				],
				"comorbidities": [
					{
						"prior_malignancy": "Yes",
						"laterality_of_prior_malignancy": "Right",
						"comorbidity_type_code": "C34.9",
						"comorbidity_treatment_status": "Unknown",
						"comorbidity_treatment": "Ablation",
						"age_at_comorbidity_diagnosis": 44
					},
					{
						"prior_malignancy": "Yes",
						"laterality_of_prior_malignancy": "Unilateral, Side not specified",
						"comorbidity_type_code": "C43.9",
						"comorbidity_treatment_status": "Yes",
						"comorbidity_treatment": "Hormonal therapy",
						"age_at_comorbidity_diagnosis": 46
					},
					{
						"prior_malignancy": "No",
						"comorbidity_type_code": "C02.1",
						"comorbidity_treatment_status": "Yes",
						"comorbidity_treatment": "Endoscopic therapy",
						"age_at_comorbidity_diagnosis": 40
					}
				],
				"exposures": [
					{
						"tobacco_smoking_status": "Current smoker",
						"tobacco_type": [
							"Unknown",
							"Electronic cigarettes",
							"Not applicable"
						],
						"pack_years_smoked": 280.0
					},
					{
						"tobacco_smoking_status": "Not applicable"
					},
					{
						"tobacco_smoking_status": "Not applicable"
					}
				],
				"biomarkers": [],
				"followups": []
			},
			{
				"submitter_donor_id": "DONOR_10",
				"program_id": "SYNTHETIC-2",
				"lost_to_followup_reason": "Not applicable",
				"date_alive_after_lost_to_followup": "2022-03",
				"is_deceased": true,
				"cause_of_death": "Unknown",
				"date_of_birth": "1987-09",
				"date_of_death": "2015-09",
				"gender": "Woman",
				"sex_at_birth": "Other",
				"primary_site": [
					"Esophagus",
					"Base of tongue",
					"Nasal cavity and middle ear"
				],
				"primary_diagnoses": [
					{
						"submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_16",
						"date_of_diagnosis": "2019-10",
						"cancer_type_code": "C43.9",
						"basis_of_diagnosis": "Histology of a primary tumour",
						"lymph_nodes_examined_status": "No lymph nodes found in resected specimen",
						"lymph_nodes_examined_method": "Physical palpation of patient",
						"number_lymph_nodes_positive": 10,
						"clinical_tumour_staging_system": "Binet staging system",
						"clinical_t_category": "T4b",
						"clinical_n_category": "N0(mol-)",
						"clinical_m_category": "M1a(1)",
						"clinical_stage_group": "Stage IBS",
						"laterality": "Bilateral",
						"specimens": [
							{
								"submitter_specimen_id": "SPECIMEN_22",
								"pathological_tumour_staging_system": "Durie-Salmon staging system",
								"pathological_t_category": "T3e",
								"pathological_n_category": "N0(mol+)",
								"pathological_m_category": "M0",
								"pathological_stage_group": "Stage IIBES",
								"specimen_collection_date": "2021-04-20",
								"specimen_storage": "Paraffin block",
								"tumour_histological_type": "8124/9",
								"specimen_anatomic_location": "C43.9",
								"reference_pathology_confirmed_diagnosis": "Unknown",
								"reference_pathology_confirmed_tumour_presence": "Not done",
								"tumour_grading_system": "Scarff-Bloom-Richardson grading system",
								"tumour_grade": "Grade Group 3",
								"percent_tumour_cells_range": "20-50%",
								"percent_tumour_cells_measurement_method": "Image analysis",
								"specimen_processing": "Other",
								"specimen_laterality": "Right",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_28",
										"specimen_tissue_source": "Venous blood",
										"tumour_normal_designation": "Tumour",
										"specimen_type": "Primary tumour - adjacent to normal",
										"sample_type": "Total RNA"
									}
								],
								"biomarkers": []
							}
						],
						"treatments": [
							{
								"submitter_treatment_id": "TREATMENT_22",
								"is_primary_treatment": "Yes",
								"treatment_start_date": "2021-10",
								"treatment_end_date": "2022-07",
								"treatment_setting": "Neoadjuvant",
								"treatment_intent": "Diagnostic",
								"days_per_cycle": 6,
								"number_of_cycles": 4,
								"line_of_treatment": 1,
								"status_of_treatment": "Treatment incomplete due to technical or organizational problems",
								"treatment_type": [
									"Surgery"
								],
								"response_to_treatment_criteria_method": "Response Assessment in Neuro-Oncology (RANO)",
								"response_to_treatment": "Partial response",
								"chemotherapies": [],
								"hormone_therapies": [],
								"immunotherapies": [],
								"surgery": {
									"surgery_type": "Pneumonectomy",
									"surgery_site": "C14",
									"surgery_location": "Primary",
									"tumour_focality": "Unifocal",
									"residual_tumour_classification": "R2",
									"margin_types_involved": [
										"Unknown"
									],
									"margin_types_not_involved": [
										"Circumferential resection margin"
									],
									"margin_types_not_assessed": [
										"Distal margin",
										"Proximal margin"
									],
									"lymphovascular_invasion": "Unknown",
									"perineural_invasion": "Unknown",
									"tumour_length": 3,
									"tumour_width": 5,
									"greatest_dimension_tumour": 5,
									"submitter_specimen_id": null
								},
								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_28",
										"date_of_followup": "2022-08",
										"disease_status_at_followup": "Loco-regional progression",
										"relapse_type": "Local recurrence",
										"date_of_relapse": "2022-06",
										"method_of_progression_status": [
											"Histopathology test (procedure)",
											"Physical examination procedure (procedure)"
										],
										"anatomic_site_progression_or_recurrence": "C10",
										"recurrence_tumour_staging_system": "AJCC 6th edition",
										"recurrence_t_category": "T3",
										"recurrence_n_category": "N0(i+)",
										"recurrence_m_category": "M1c(0)",
										"recurrence_stage_group": "Stage 4",
										"biomarkers": []
									}
								],
								"biomarkers": []
							}
						],
						"biomarkers": [],
						"followups": []
					}
				],
				"comorbidities": [],
				"exposures": [],
				"biomarkers": [],
				"followups": []
			},
			{
				"submitter_donor_id": "DONOR_2",
				"program_id": "SYNTHETIC-2",
				"lost_to_followup_reason": "Discharged to palliative care",
				"lost_to_followup_after_clinical_event_identifier": "",
				"date_alive_after_lost_to_followup": "2022-10",
				"is_deceased": false,
				"cause_of_death": "Died of other reasons",
				"date_of_birth": "1994-06",
				"date_of_death": null,
				"gender": "Man",
				"sex_at_birth": "Male",
				"primary_site": [
					"Bronchus and lung",
					"Larynx",
					"Pancreas"
				],
				"primary_diagnoses": [
					{
						"submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_4",
						"date_of_diagnosis": "2019-09",
						"cancer_type_code": "C04.9",
						"basis_of_diagnosis": "Clinical investigation",
						"lymph_nodes_examined_status": "Not applicable",
						"lymph_nodes_examined_method": "Physical palpation of patient",
						"number_lymph_nodes_positive": 8,
						"clinical_tumour_staging_system": "International Neuroblastoma Risk Group Staging System",
						"clinical_t_category": "T4a",
						"clinical_n_category": "N0",
						"clinical_m_category": "M1b(1)",
						"clinical_stage_group": "Stage IIA1",
						"laterality": "Unknown",
						"specimens": [
							{
								"submitter_specimen_id": "SPECIMEN_10",
								"pathological_tumour_staging_system": "Rai staging system",
								"pathological_t_category": "TX",
								"pathological_n_category": "N0",
								"pathological_m_category": "M1d(1)",
								"pathological_stage_group": "Stage 1",
								"specimen_collection_date": "2020-12-26",
								"specimen_storage": "Cut slide",
								"tumour_histological_type": "8630/9",
								"specimen_anatomic_location": "C34.9",
								"reference_pathology_confirmed_diagnosis": "Unknown",
								"reference_pathology_confirmed_tumour_presence": "Yes",
								"tumour_grading_system": "Nuclear grading system for DCIS",
								"tumour_grade": "High grade",
								"percent_tumour_cells_range": "51-100%",
								"percent_tumour_cells_measurement_method": "Pathology estimate by percent nuclei",
								"specimen_processing": "Cryopreservation of live cells in liquid nitrogen",
								"specimen_laterality": "Right",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_16",
										"specimen_tissue_source": "Bile",
										"tumour_normal_designation": "Normal",
										"specimen_type": "Metastatic tumour - additional metastatic",
										"sample_type": "polyA+ RNA"
									}
								],
								"biomarkers": []
							},
							{
								"submitter_specimen_id": "SPECIMEN_9",
								"pathological_tumour_staging_system": "AJCC 6th edition",
								"pathological_t_category": "T4b",
								"pathological_n_category": "N0a (biopsy)",
								"pathological_m_category": "M1a(0)",
								"pathological_stage_group": "Stage IIID",
								"specimen_collection_date": "2021-07-29",
								"specimen_storage": "RNA later frozen",
								"tumour_histological_type": "8973/2",
								"specimen_anatomic_location": "C43.9",
								"reference_pathology_confirmed_diagnosis": "Unknown",
								"reference_pathology_confirmed_tumour_presence": "Unknown",
								"tumour_grading_system": "FNCLCC grading system",
								"tumour_grade": "Grade 2",
								"percent_tumour_cells_range": "20-50%",
								"percent_tumour_cells_measurement_method": "Pathology estimate by percent nuclei",
								"specimen_processing": "Formalin fixed - unbuffered",
								"specimen_laterality": "Not applicable",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_15",
										"specimen_tissue_source": "Blood derived - peripheral blood",
										"tumour_normal_designation": "Tumour",
										"specimen_type": "Recurrent tumour",
										"sample_type": "Total RNA"
									}
								],
								"biomarkers": []
							}
						],
						"treatments": [
							{
								"submitter_treatment_id": "TREATMENT_10",
								"is_primary_treatment": "Unknown",
								"treatment_start_date": "2021-08",
								"treatment_end_date": "2022-10",
								"treatment_setting": "Salvage",
								"treatment_intent": "Forensic",
								"days_per_cycle": 1,
								"number_of_cycles": 5,
								"line_of_treatment": 5,
								"status_of_treatment": "Not applicable",
								"treatment_type": [
									"Radiation therapy",
									"Bone marrow transplant",
									"No treatment"
								],
								"response_to_treatment_criteria_method": "Physician Assessed Response Criteria",
								"response_to_treatment": "No evidence of disease (NED)",
								"chemotherapies": [],
								"hormone_therapies": [],
								"immunotherapies": [],
								"radiation": {
									"radiation_therapy_modality": "Teleradiotherapy protons (procedure)",
									"radiation_therapy_type": "Internal",
									"anatomical_site_irradiated": "Finger (Including Thumbs)",
									"radiation_therapy_fractions": 30,
									"radiation_therapy_dosage": 66,
									"radiation_boost": true,
									"reference_radiation_treatment_id": "REFERENCE_RADIATION_TREATMENT_2"
								},

								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_16",
										"date_of_followup": "2022-09",
										"disease_status_at_followup": "Loco-regional progression",
										"relapse_type": "Distant recurrence/metastasis",
										"date_of_relapse": "2022-10",
										"method_of_progression_status": [
											"Laboratory data interpretation (procedure)",
											"Histopathology test (procedure)"
										],
										"anatomic_site_progression_or_recurrence": "C14",
										"recurrence_tumour_staging_system": "St Jude staging system",
										"recurrence_t_category": "T2(m)",
										"recurrence_n_category": "N0b",
										"recurrence_m_category": "M1c(1)",
										"recurrence_stage_group": "Stage IB",
										"biomarkers": []
									}
								],
								"biomarkers": []
							},
							{
								"submitter_treatment_id": "TREATMENT_9",
								"is_primary_treatment": "Unknown",
								"treatment_start_date": "2021-07",
								"treatment_end_date": "2022-11",
								"treatment_setting": "Maintenance",
								"treatment_intent": "Supportive",
								"days_per_cycle": 7,
								"number_of_cycles": 5,
								"line_of_treatment": 4,
								"status_of_treatment": "Treatment incomplete due to technical or organizational problems",
								"treatment_type": [
									"Surgery"
								],
								"response_to_treatment_criteria_method": "RECIST 1.1",
								"response_to_treatment": "Immune confirmed progressive disease (iCPD)",
								"chemotherapies": [],
								"hormone_therapies": [],
								"immunotherapies": [],
								"radiation": {
									"radiation_therapy_modality": "Teleradiotherapy neutrons (procedure)",
									"radiation_therapy_type": "Internal",
									"anatomical_site_irradiated": "Left Maxilla",
									"radiation_therapy_fractions": 30,
									"radiation_therapy_dosage": 66,
									"radiation_boost": true,
									"reference_radiation_treatment_id": "REFERENCE_RADIATION_TREATMENT_1"
								},

								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_15",
										"date_of_followup": "2022-08",
										"disease_status_at_followup": "Partial remission",
										"relapse_type": "Biochemical progression",
										"date_of_relapse": "2022-02",
										"method_of_progression_status": [],
										"anatomic_site_progression_or_recurrence": "C16",
										"recurrence_tumour_staging_system": "Durie-Salmon staging system",
										"recurrence_t_category": "T2a",
										"recurrence_n_category": "N2",
										"recurrence_m_category": "M1c",
										"recurrence_stage_group": "Stage A",
										"biomarkers": []
									}
								],
								"biomarkers": []
							}
						],
						"biomarkers": [
							{
								"er_status": "Cannot be determined",
								"pr_status": "Negative",
								"her2_ihc_status": "Unknown",
								"her2_ish_status": "Not applicable",
								"hpv_ihc_status": "Not applicable",
								"hpv_pcr_status": "Positive",
								"hpv_strain": [
									"HPV35"
								],
								"test_interval": 6,
								"psa_level": 304,
								"ca125": 111,
								"cea": 9,
								"er_percent_positive": 1.3,
								"pr_percent_positive": 15.1
							}
						],
						"followups": []
					},
					{
						"submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_5",
						"date_of_diagnosis": "2019-02",
						"cancer_type_code": "C02.1",
						"basis_of_diagnosis": "Clinical",
						"lymph_nodes_examined_status": "Yes",
						"lymph_nodes_examined_method": "Physical palpation of patient",
						"number_lymph_nodes_positive": 15,
						"clinical_tumour_staging_system": "Ann Arbor staging system",
						"clinical_t_category": "T4",
						"clinical_n_category": "N3b",
						"clinical_m_category": "M1d(1)",
						"clinical_stage_group": "Stage IAS",
						"laterality": "Left",
						"specimens": [
							{
								"submitter_specimen_id": "SPECIMEN_11",
								"pathological_tumour_staging_system": "AJCC 6th edition",
								"pathological_t_category": "T1b(s)",
								"pathological_n_category": "N3c",
								"pathological_m_category": "M1",
								"pathological_stage_group": "Stage II bulky",
								"specimen_collection_date": "2021-10-26",
								"specimen_storage": "Frozen in liquid nitrogen",
								"tumour_histological_type": "8980/9",
								"specimen_anatomic_location": "C43.1",
								"reference_pathology_confirmed_diagnosis": "Not done",
								"reference_pathology_confirmed_tumour_presence": "Unknown",
								"tumour_grading_system": "Gleason grade group system",
								"tumour_grade": "Grade 4",
								"percent_tumour_cells_range": "0-19%",
								"percent_tumour_cells_measurement_method": "Pathology estimate by percent nuclei",
								"specimen_processing": "Fresh",
								"specimen_laterality": "Not applicable",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_17",
										"specimen_tissue_source": "Pancreatic fluid",
										"tumour_normal_designation": "Normal",
										"specimen_type": "Metastatic tumour - additional metastatic",
										"sample_type": "Total DNA"
									}
								],
								"biomarkers": []
							}
						],
						"treatments": [
							{
								"submitter_treatment_id": "TREATMENT_11",
								"is_primary_treatment": "Yes",
								"treatment_start_date": "2021-11",
								"treatment_end_date": "2022-06",
								"treatment_setting": "Induction",
								"treatment_intent": "Curative",
								"days_per_cycle": 4,
								"number_of_cycles": 5,
								"line_of_treatment": 1,
								"status_of_treatment": "Treatment stopped due to acute toxicity",
								"treatment_type": [
									"Hormonal therapy",
									"Other targeting molecular therapy",
									"Surgery"
								],
								"response_to_treatment_criteria_method": "RECIST 1.1",
								"response_to_treatment": "Physician assessed stable disease",
								"chemotherapies": [],
								"hormone_therapies": [],
								"immunotherapies": [],
								"radiation": {
									"radiation_therapy_modality": "Teleradiotherapy neutrons (procedure)",
									"radiation_therapy_type": "External",
									"anatomical_site_irradiated": "Left Scapula",
									"radiation_therapy_fractions": 35,
									"radiation_therapy_dosage": 70,
									"radiation_boost": true,
									"reference_radiation_treatment_id": "REFERENCE_RADIATION_TREATMENT_3"
								},

								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_17",
										"date_of_followup": "2022-10",
										"disease_status_at_followup": "Progression not otherwise specified",
										"relapse_type": "Biochemical progression",
										"date_of_relapse": "2022-01",
										"method_of_progression_status": [],
										"anatomic_site_progression_or_recurrence": "C14",
										"recurrence_tumour_staging_system": "AJCC 6th edition",
										"recurrence_t_category": "T1a2",
										"recurrence_n_category": "N0(mol-)",
										"recurrence_m_category": "M1a(1)",
										"recurrence_stage_group": "Stage IVAES",
										"biomarkers": []
									}
								],
								"biomarkers": []
							}
						],
						"biomarkers": [],
						"followups": []
					},
					{
						"submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_6",
						"date_of_diagnosis": "2019-10",
						"cancer_type_code": "C43.1",
						"basis_of_diagnosis": "Death certificate only",
						"lymph_nodes_examined_status": "Not applicable",
						"lymph_nodes_examined_method": "Physical palpation of patient",
						"number_lymph_nodes_positive": 6,
						"clinical_tumour_staging_system": "International Neuroblastoma Risk Group Staging System",
						"clinical_t_category": "T2b",
						"clinical_n_category": "N0a (biopsy)",
						"clinical_m_category": "M0(i+)",
						"clinical_stage_group": "Stage IIIC2",
						"laterality": "Left",
						"specimens": [
							{
								"submitter_specimen_id": "SPECIMEN_12",
								"pathological_tumour_staging_system": "FIGO staging system",
								"clinical_stage_group": "Stage IIS",
								"pathological_t_category": "Tis pd",
								"pathological_n_category": "N1b",
								"pathological_m_category": "M0(i+)",
								"pathological_stage_group": "Stage IV",
								"specimen_collection_date": "2020-07-07",
								"specimen_storage": "Unknown",
								"tumour_histological_type": "8962/1",
								"specimen_anatomic_location": "C64.9",
								"reference_pathology_confirmed_diagnosis": "Not done",
								"reference_pathology_confirmed_tumour_presence": "No",
								"tumour_grading_system": "Three-tier grading system",
								"tumour_grade": "High",
								"percent_tumour_cells_range": "0-19%",
								"percent_tumour_cells_measurement_method": "Pathology estimate by percent nuclei",
								"specimen_processing": "Cryopreservation of live cells in liquid nitrogen",
								"specimen_laterality": "Left",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_18",
										"specimen_tissue_source": "Blood derived - bone marrow",
										"tumour_normal_designation": "Tumour",
										"specimen_type": "Cell line - derived from primary tumour",
										"sample_type": "Other RNA fractions"
									}
								],
								"biomarkers": []
							}
						],
						"treatments": [
							{
								"submitter_treatment_id": "TREATMENT_12",
								"is_primary_treatment": "Unknown",
								"treatment_start_date": "2021-08",
								"treatment_end_date": "2022-11",
								"treatment_setting": "Mobilization",
								"treatment_intent": "Forensic",
								"days_per_cycle": 2,
								"number_of_cycles": 5,
								"line_of_treatment": 5,
								"status_of_treatment": "Physician decision (stopped or interrupted treatment)",
								"treatment_type": [
									"Other targeting molecular therapy",
									"Surgery"
								],
								"response_to_treatment_criteria_method": "Physician Assessed Response Criteria",
								"response_to_treatment": "Partial remission",
								"chemotherapies": [],
								"hormone_therapies": [],
								"immunotherapies": [],
								"radiation": {
									"radiation_therapy_modality": "Megavoltage radiation therapy using photons (procedure)",
									"radiation_therapy_type": "Internal",
									"anatomical_site_irradiated": "Right Adrenal",
									"radiation_therapy_fractions": 30,
									"radiation_therapy_dosage": 70,
									"radiation_boost": false,
									"reference_radiation_treatment_id": ""
								},
								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_18",
										"date_of_followup": "2022-10",
										"disease_status_at_followup": "Distant progression",
										"relapse_type": "Progression (liquid tumours)",
										"date_of_relapse": "2022-04",
										"method_of_progression_status": [
											"Histopathology test (procedure)",
											"Imaging (procedure)"
										],
										"anatomic_site_progression_or_recurrence": "C20",
										"recurrence_tumour_staging_system": "International Neuroblastoma Risk Group Staging System",
										"recurrence_t_category": "T1c",
										"recurrence_n_category": "N2b",
										"recurrence_m_category": "M1c(0)",
										"recurrence_stage_group": "Stage IIIC1",
										"biomarkers": []
									}
								],
								"biomarkers": []
							}
						],
						"biomarkers": [],
						"followups": []
					}
				],
				"comorbidities": [
					{
						"prior_malignancy": "Unknown",
						"comorbidity_type_code": "C04.0",
						"comorbidity_treatment_status": "Yes",
						"comorbidity_treatment": "Other targeting molecular therapy",
						"age_at_comorbidity_diagnosis": 57
					},
					{
						"prior_malignancy": "No",
						"comorbidity_type_code": "C34.9",
						"comorbidity_treatment_status": "Unknown",
						"comorbidity_treatment": "Endoscopic therapy",
						"age_at_comorbidity_diagnosis": 56
					},
					{
						"prior_malignancy": "Yes",
						"laterality_of_prior_malignancy": "Bilateral",
						"comorbidity_type_code": "C50.9",
						"comorbidity_treatment_status": "No",
						"comorbidity_treatment": "Surgery",
						"age_at_comorbidity_diagnosis": 53
					}
				],
				"exposures": [
					{
						"tobacco_smoking_status": "Current reformed smoker for > 15 years",
						"tobacco_type": [
							"Cigarettes",
							"Electronic cigarettes"
						],
						"pack_years_smoked": 90.0
					},
					{
						"tobacco_smoking_status": "Current smoker",
						"tobacco_type": [
							"Cigarettes",
							"Snuff"
						],
						"pack_years_smoked": 266.0
					}
				],
				"biomarkers": [],
				"followups": []
			},
			{
				"submitter_donor_id": "DONOR_3",
				"program_id": "SYNTHETIC-2",
				"lost_to_followup_reason": "Discharged to palliative care",
				"lost_to_followup_after_clinical_event_identifier": "",
				"date_alive_after_lost_to_followup": "2022-01",
				"is_deceased": true,
				"cause_of_death": "Unknown",
				"date_of_birth": "2005-08",
				"date_of_death": "2011-08",
				"gender": "Non-binary",
				"sex_at_birth": "Female",
				"primary_site": [
					"Penis"
				],
				"primary_diagnoses": [
					{
						"submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_7",
						"date_of_diagnosis": "2019-09",
						"cancer_type_code": "C05.1",
						"basis_of_diagnosis": "Death certificate only",
						"lymph_nodes_examined_status": "Yes",
						"lymph_nodes_examined_method": "Imaging",
						"number_lymph_nodes_positive": 9,
						"clinical_tumour_staging_system": "Ann Arbor staging system",
						"clinical_t_category": "Tis(Paget)",
						"clinical_n_category": "N3b",
						"clinical_m_category": "M1a",
						"clinical_stage_group": "Stage IIIES",
						"laterality": "Right",
						"specimens": [
							{
								"submitter_specimen_id": "SPECIMEN_13",
								"pathological_tumour_staging_system": "AJCC 8th edition",
								"pathological_t_category": "T1a(m)",
								"pathological_n_category": "N3b",
								"pathological_m_category": "M1b(0)",
								"pathological_stage_group": "Stage A",
								"specimen_collection_date": "2020-05-06",
								"specimen_storage": "RNA later frozen",
								"tumour_histological_type": "8124/9",
								"specimen_anatomic_location": "C64.9",
								"reference_pathology_confirmed_diagnosis": "Not done",
								"reference_pathology_confirmed_tumour_presence": "Unknown",
								"tumour_grading_system": "IASLC grading system",
								"tumour_grade": "Grade Group 3",
								"percent_tumour_cells_range": "20-50%",
								"percent_tumour_cells_measurement_method": "Image analysis",
								"specimen_processing": "Unknown",
								"specimen_laterality": "Not applicable",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_19",
										"specimen_tissue_source": "Solid tissue",
										"tumour_normal_designation": "Tumour",
										"specimen_type": "Metastatic tumour",
										"sample_type": "Other RNA fractions"
									}
								],
								"biomarkers": []
							}
						],
						"treatments": [
							{
								"submitter_treatment_id": "TREATMENT_13",
								"is_primary_treatment": "No",
								"treatment_start_date": "2021-03",
								"treatment_end_date": "2022-09",
								"treatment_setting": "Mobilization",
								"treatment_intent": "Guidance",
								"days_per_cycle": 6,
								"number_of_cycles": 5,
								"line_of_treatment": 4,
								"status_of_treatment": "Treatment incomplete due to technical or organizational problems",
								"treatment_type": [
									"Chemotherapy",
									"Stem cell transplant",
									"Bone marrow transplant"
								],
								"response_to_treatment_criteria_method": "Physician Assessed Response Criteria",
								"response_to_treatment": "Partial remission",
								"chemotherapies": [],
								"hormone_therapies": [],
								"immunotherapies": [],
								"radiation": {
									"radiation_therapy_modality": "Brachytherapy (procedure)",
									"radiation_therapy_type": "External",
									"anatomical_site_irradiated": "Bilateral Ovary",
									"radiation_therapy_fractions": 30,
									"radiation_therapy_dosage": 66,
									"radiation_boost": false,
									"reference_radiation_treatment_id": ""
								},

								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_19",
										"date_of_followup": "2022-09",
										"disease_status_at_followup": "Complete remission",
										"relapse_type": "Progression (liquid tumours)",
										"date_of_relapse": "2022-01",
										"method_of_progression_status": [
											"Histopathology test (procedure)",
											"Laboratory data interpretation (procedure)"
										],
										"anatomic_site_progression_or_recurrence": "C14",
										"recurrence_tumour_staging_system": "International Neuroblastoma Staging System",
										"recurrence_t_category": "T2a2",
										"recurrence_n_category": "N3",
										"recurrence_m_category": "M0",
										"recurrence_stage_group": "Stage IAS",
										"biomarkers": []
									}
								],
								"biomarkers": []
							}
						],
						"biomarkers": [],
						"followups": []
					},
					{
						"submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_8",
						"date_of_diagnosis": "2019-05",
						"cancer_type_code": "C43.1",
						"basis_of_diagnosis": "Clinical investigation",
						"lymph_nodes_examined_status": "No",
						"lymph_nodes_examined_method": "Lymph node dissection/pathological exam",
						"number_lymph_nodes_positive": 7,
						"clinical_tumour_staging_system": "FIGO staging system",
						"clinical_t_category": "T3a",
						"clinical_n_category": "N4",
						"clinical_m_category": "M0",
						"clinical_stage_group": "Stage IIS",
						"laterality": "Bilateral",
						"specimens": [
							{
								"submitter_specimen_id": "SPECIMEN_14",
								"pathological_tumour_staging_system": "SEER staging system",
								"pathological_t_category": "T4c",
								"pathological_n_category": "N1a(sn)",
								"pathological_m_category": "M1b(0)",
								"pathological_stage_group": "Stage IAB",
								"specimen_collection_date": "2021-11-26",
								"specimen_storage": "Other",
								"tumour_histological_type": "8289/9",
								"specimen_anatomic_location": "C43.9",
								"reference_pathology_confirmed_diagnosis": "Not done",
								"reference_pathology_confirmed_tumour_presence": "No",
								"tumour_grading_system": "FNCLCC grading system",
								"tumour_grade": "High grade",
								"percent_tumour_cells_range": "51-100%",
								"percent_tumour_cells_measurement_method": "Unknown",
								"specimen_processing": "Unknown",
								"specimen_laterality": "Unknown",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_20",
										"specimen_tissue_source": "Sputum",
										"tumour_normal_designation": "Normal",
										"specimen_type": "Normal",
										"sample_type": "Protein"
									}
								],
								"biomarkers": []
							}
						],
						"treatments": [
							{
								"submitter_treatment_id": "TREATMENT_14",
								"is_primary_treatment": "No",
								"treatment_start_date": "2021-09",
								"treatment_end_date": "2022-11",
								"treatment_setting": "Preventative",
								"treatment_intent": "Palliative",
								"days_per_cycle": 2,
								"number_of_cycles": 4,
								"line_of_treatment": 3,
								"status_of_treatment": "Treatment stopped due to lack of efficacy (disease progression)",
								"treatment_type": [
									"Chemotherapy",
									"Immunotherapy",
									"Stem cell transplant"
								],
								"response_to_treatment_criteria_method": "RECIST 1.1",
								"response_to_treatment": "Immune complete response (iCR)",
								"chemotherapies": [],
								"hormone_therapies": [],
								"immunotherapies": [
									{
										"immunotherapy_type": "Cell-based",
										"drug_reference_database": "RxNorm",
										"immunotherapy_drug_dose_units": "IU/kg",
										"drug_name": "Pembrolizumab",
										"drug_reference_identifier": "4459876",
										"prescribed_cumulative_drug_dose": 95,
										"actual_cumulative_drug_dose": 160
									},
									{
										"immunotherapy_type": "Other immunomodulatory substances",
										"drug_reference_database": "PubChem",
										"immunotherapy_drug_dose_units": "ug/m2",
										"drug_name": "Pexidartinib",
										"drug_reference_identifier": "8836851",
										"prescribed_cumulative_drug_dose": 197,
										"actual_cumulative_drug_dose": 183
									},
									{
										"immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
										"drug_reference_database": "RxNorm",
										"immunotherapy_drug_dose_units": "cells/kg",
										"drug_name": "Copanlisib",
										"drug_reference_identifier": "278936",
										"prescribed_cumulative_drug_dose": 183,
										"actual_cumulative_drug_dose": 100
									}
								],

								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_20",
										"date_of_followup": "2022-11",
										"disease_status_at_followup": "Distant progression",
										"relapse_type": "Local recurrence and distant metastasis",
										"date_of_relapse": "2022-09",
										"method_of_progression_status": [],
										"anatomic_site_progression_or_recurrence": "C20",
										"recurrence_tumour_staging_system": "AJCC 8th edition",
										"recurrence_t_category": "T3a",
										"recurrence_n_category": "N0(i-)",
										"recurrence_m_category": "M1b(0)",
										"recurrence_stage_group": "Stage IVBE",
										"biomarkers": []
									}
								],
								"biomarkers": []
							}
						],
						"biomarkers": [],
						"followups": []
					}
				],
				"comorbidities": [
					{
						"prior_malignancy": "Yes",
						"laterality_of_prior_malignancy": "Bilateral",
						"comorbidity_type_code": "C67.6",
						"comorbidity_treatment_status": "Unknown",
						"comorbidity_treatment": "Ablation",
						"age_at_comorbidity_diagnosis": 41
					},
					{
						"prior_malignancy": "No",
						"comorbidity_type_code": "C43.9",
						"comorbidity_treatment_status": "Unknown",
						"comorbidity_treatment": "Endoscopic therapy",
						"age_at_comorbidity_diagnosis": 46
					}
				],
				"exposures": [
					{
						"tobacco_smoking_status": "Current reformed smoker for > 15 years",
						"tobacco_type": [
							"Waterpipe",
							"Unknown"
						],
						"pack_years_smoked": 29.0
					}
				],
				"biomarkers": [
					{
						"er_status": "Cannot be determined",
						"pr_status": "Unknown",
						"her2_ihc_status": "Not applicable",
						"her2_ish_status": "Cannot be determined",
						"hpv_ihc_status": "Negative",
						"hpv_pcr_status": "Cannot be determined",
						"hpv_strain": [
							"HPV39",
							"HPV16"
						],
						"test_interval": 4,
						"psa_level": 245,
						"ca125": 46,
						"cea": 11,
						"er_percent_positive": 59.9,
						"pr_percent_positive": 39.7
					}
				],
				"followups": []
			},
			{
				"submitter_donor_id": "DONOR_4",
				"program_id": "SYNTHETIC-2",
				"lost_to_followup_after_clinical_event_identifier": "",
				"lost_to_followup_reason": "Withdrew from study",
				"date_alive_after_lost_to_followup": "2022-04",
				"is_deceased": false,
				"cause_of_death": "Died of cancer",
				"date_of_birth": "1984-10",
				"date_of_death": null,
				"gender": "Man",
				"sex_at_birth": "Male",
				"primary_site": [
					"Skin",
					"Bronchus and lung",
					"Prostate gland"
				],
				"primary_diagnoses": [
					{
						"submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_10",
						"date_of_diagnosis": "2019-05",
						"cancer_type_code": "C43.9",
						"basis_of_diagnosis": "Cytology",
						"lymph_nodes_examined_status": "Cannot be determined",
						"lymph_nodes_examined_method": "Lymph node dissection/pathological exam",
						"number_lymph_nodes_positive": 4,
						"clinical_tumour_staging_system": "International Neuroblastoma Staging System",
						"clinical_t_category": "Tis(Paget)",
						"clinical_n_category": "N2a",
						"clinical_m_category": "M1e",
						"clinical_stage_group": "Stage Ms",
						"laterality": "Left",
						"specimens": [
							{
								"submitter_specimen_id": "SPECIMEN_16",
								"pathological_tumour_staging_system": "Revised International staging system (RISS)",
								"pathological_t_category": "T2(m)",
								"pathological_n_category": "N1a(sn)",
								"pathological_m_category": "M1c",
								"pathological_stage_group": "Stage IIBE",
								"specimen_collection_date": "2020-07-14",
								"specimen_storage": "Frozen in vapour phase",
								"tumour_histological_type": "8240/1",
								"specimen_anatomic_location": "C67.6",
								"reference_pathology_confirmed_diagnosis": "Not done",
								"reference_pathology_confirmed_tumour_presence": "Not done",
								"tumour_grading_system": "Scarff-Bloom-Richardson grading system",
								"tumour_grade": "Grade 2",
								"percent_tumour_cells_range": "20-50%",
								"percent_tumour_cells_measurement_method": "Pathology estimate by percent nuclei",
								"specimen_processing": "Cryopreservation in dry ice (dead tissue)",
								"specimen_laterality": "Unknown",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_22",
										"specimen_tissue_source": "Cervical mucus",
										"tumour_normal_designation": "Tumour",
										"specimen_type": "Primary tumour - additional new primary",
										"sample_type": "ctDNA"
									}
								],
								"biomarkers": []
							}
						],
						"treatments": [
							{
								"submitter_treatment_id": "TREATMENT_16",
								"is_primary_treatment": "Yes",
								"treatment_start_date": "2021-01",
								"treatment_end_date": "2022-04",
								"treatment_setting": "Conditioning",
								"treatment_intent": "Diagnostic",
								"days_per_cycle": 2,
								"number_of_cycles": 4,
								"line_of_treatment": 5,
								"status_of_treatment": "Patient choice (stopped or interrupted treatment)",
								"treatment_type": [
									"Bone marrow transplant",
									"Surgery",
									"Radiation therapy"
								],
								"response_to_treatment_criteria_method": "iRECIST",
								"response_to_treatment": "Physician assessed partial response",
								"chemotherapies": [],
								"hormone_therapies": [],
								"immunotherapies": [
									{
										"immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
										"drug_reference_database": "RxNorm",
										"immunotherapy_drug_dose_units": "IU/kg",
										"drug_name": "Copanlisib",
										"drug_reference_identifier": "239766",
										"prescribed_cumulative_drug_dose": 181,
										"actual_cumulative_drug_dose": 111
									}
								],

								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_22",
										"date_of_followup": "2022-10",
										"disease_status_at_followup": "Stable",
										"relapse_type": "Distant recurrence/metastasis",
										"date_of_relapse": "2021-11",
										"method_of_progression_status": [
											"Tumor marker measurement (procedure)",
											"Physical examination procedure (procedure)"
										],
										"anatomic_site_progression_or_recurrence": "C18",
										"recurrence_tumour_staging_system": "Binet staging system",
										"recurrence_t_category": "T1a(s)",
										"recurrence_n_category": "N0a (biopsy)",
										"recurrence_m_category": "M1e",
										"recurrence_stage_group": "Stage IIBES",
										"biomarkers": []
									}
								],
								"biomarkers": []
							}
						],
						"biomarkers": [],
						"followups": []
					},
					{
						"submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_9",
						"date_of_diagnosis": "2019-06",
						"cancer_type_code": "C04.9",
						"basis_of_diagnosis": "Clinical",
						"lymph_nodes_examined_status": "No lymph nodes found in resected specimen",
						"lymph_nodes_examined_method": "Imaging",
						"number_lymph_nodes_positive": 15,
						"clinical_tumour_staging_system": "AJCC 7th edition",
						"clinical_t_category": "T1a2",
						"clinical_n_category": "N2c",
						"clinical_m_category": "M1a(0)",
						"clinical_stage_group": "Stage IIIBES",
						"laterality": "Unilateral, side not specified",
						"specimens": [
							{
								"submitter_specimen_id": "SPECIMEN_15",
								"pathological_tumour_staging_system": "International Neuroblastoma Risk Group Staging System",
								"pathological_t_category": "T1b(s)",
								"pathological_n_category": "N4",
								"pathological_m_category": "M1c",
								"pathological_stage_group": "Stage IVB",
								"specimen_collection_date": "2020-05-31",
								"specimen_storage": "RNA later frozen",
								"tumour_histological_type": "8250/3",
								"specimen_anatomic_location": "C43.9",
								"reference_pathology_confirmed_diagnosis": "Yes",
								"reference_pathology_confirmed_tumour_presence": "Not done",
								"tumour_grading_system": "Grading system for GNETs",
								"tumour_grade": "High",
								"percent_tumour_cells_range": "0-19%",
								"percent_tumour_cells_measurement_method": "Pathology estimate by percent nuclei",
								"specimen_processing": "Cryopreservation of live cells in liquid nitrogen",
								"specimen_laterality": "Not applicable",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_21",
										"specimen_tissue_source": "Buccal cell",
										"tumour_normal_designation": "Tumour",
										"specimen_type": "Recurrent tumour",
										"sample_type": "Protein"
									}
								],
								"biomarkers": []
							}
						],
						"treatments": [
							{
								"submitter_treatment_id": "TREATMENT_15",
								"is_primary_treatment": "Yes",
								"treatment_start_date": "2021-12",
								"treatment_end_date": "2022-07",
								"treatment_setting": "Locally advanced",
								"treatment_intent": "Guidance",
								"days_per_cycle": 5,
								"number_of_cycles": 3,
								"line_of_treatment": 2,
								"status_of_treatment": "Treatment stopped due to lack of efficacy (disease progression)",
								"treatment_type": [
									"Stem cell transplant",
									"Immunotherapy",
									"Hormonal therapy"
								],
								"response_to_treatment_criteria_method": "Response Assessment in Neuro-Oncology (RANO)",
								"response_to_treatment": "Complete remission with incomplete hematologic recovery (CRi)",
								"chemotherapies": [],
								"hormone_therapies": [],
								"immunotherapies": [
									{
										"immunotherapy_type": "Cell-based",
										"drug_reference_database": "NCI Thesaurus",
										"immunotherapy_drug_dose_units": "IU/kg",
										"drug_name": "Necitumumab",
										"drug_reference_identifier": "278936",
										"prescribed_cumulative_drug_dose": 138,
										"actual_cumulative_drug_dose": 167
									},
									{
										"immunotherapy_type": "Immune checkpoint inhibitors",
										"drug_reference_database": "PubChem",
										"immunotherapy_drug_dose_units": "g/m2",
										"drug_name": "Pexidartinib",
										"drug_reference_identifier": "278936",
										"prescribed_cumulative_drug_dose": 184,
										"actual_cumulative_drug_dose": 190
									}
								],

								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_21",
										"disease_status_at_followup": "Loco-regional progression",
										"relapse_type": "Progression (liquid tumours)",
										"date_of_relapse": "2021-12",
										"method_of_progression_status": [],
										"anatomic_site_progression_or_recurrence": "C18",
										"recurrence_tumour_staging_system": "International Neuroblastoma Risk Group Staging System",
										"recurrence_t_category": "T4",
										"recurrence_n_category": "N0a (biopsy)",
										"recurrence_m_category": "M1",
										"recurrence_stage_group": "Stage IB2",
										"biomarkers": []
									}
								],
								"biomarkers": []
							}
						],
						"biomarkers": [],
						"followups": []
					}
				],
				"comorbidities": [
					{
						"prior_malignancy": "No",
						"comorbidity_type_code": "C67.6",
						"comorbidity_treatment_status": "Unknown",
						"comorbidity_treatment": "Radiation therapy",
						"age_at_comorbidity_diagnosis": 47
					},
					{
						"prior_malignancy": "No",
						"comorbidity_type_code": "C02.0",
						"comorbidity_treatment_status": "No",
						"comorbidity_treatment": "Photodynamic therapy",
						"age_at_comorbidity_diagnosis": 35
					}
				],
				"exposures": [],
				"biomarkers": [],
				"followups": []
			},
			{
				"submitter_donor_id": "DONOR_5",
				"program_id": "SYNTHETIC-2",
				"lost_to_followup_reason": "Completed study",
				"lost_to_followup_after_clinical_event_identifier": "",
				"date_alive_after_lost_to_followup": "2022-02",
				"is_deceased": true,
				"cause_of_death": "Died of other reasons",
				"date_of_birth": "1998-08",
				"date_of_death": "2013-08",
				"gender": "Non-binary",
				"sex_at_birth": "Other",
				"primary_site": [
					"Connective, subcutaneous and other soft tissues",
					"Penis",
					"Thyroid gland",
					"Adrenal gland"
				],
				"primary_diagnoses": [
					{
						"submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_11",
						"date_of_diagnosis": "2019-07",
						"cancer_type_code": "C64.9",
						"basis_of_diagnosis": "Specific tumour markers",
						"lymph_nodes_examined_status": "Cannot be determined",
						"lymph_nodes_examined_method": "Physical palpation of patient",
						"number_lymph_nodes_positive": 15,
						"clinical_tumour_staging_system": "Rai staging system",
						"clinical_t_category": "T4b",
						"clinical_n_category": "N0(i+)",
						"clinical_m_category": "M1e",
						"clinical_stage_group": "Stage IIBES",
						"laterality": "Bilateral",
						"specimens": [
							{
								"submitter_specimen_id": "SPECIMEN_17",
								"pathological_tumour_staging_system": "AJCC 8th edition",
								"pathological_t_category": "T4a(m)",
								"pathological_n_category": "N0b",
								"pathological_m_category": "M1c(0)",
								"pathological_stage_group": "Stage IIIA2",
								"specimen_collection_date": "2021-03-02",
								"specimen_storage": "Frozen in -70 freezer",
								"tumour_histological_type": "8970/3",
								"specimen_anatomic_location": "C43.9",
								"reference_pathology_confirmed_diagnosis": "Unknown",
								"reference_pathology_confirmed_tumour_presence": "Yes",
								"tumour_grading_system": "Grading system for GISTs",
								"tumour_grade": "Grade 4",
								"percent_tumour_cells_range": "0-19%",
								"percent_tumour_cells_measurement_method": "Image analysis",
								"specimen_processing": "Unknown",
								"specimen_laterality": "Not applicable",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_23",
										"specimen_tissue_source": "Pleural fluid",
										"tumour_normal_designation": "Tumour",
										"specimen_type": "Xenograft - derived from metastatic tumour",
										"sample_type": "Other RNA fractions"
									}
								],
								"biomarkers": []
							}
						],
						"treatments": [
							{
								"submitter_treatment_id": "TREATMENT_17",
								"is_primary_treatment": "Yes",
								"treatment_start_date": "2021-02",
								"treatment_end_date": "2022-06",
								"treatment_setting": "Conditioning",
								"treatment_intent": "Forensic",
								"days_per_cycle": 6,
								"number_of_cycles": 3,
								"line_of_treatment": 1,
								"status_of_treatment": "Treatment incomplete due to technical or organizational problems",
								"treatment_type": [
									"Immunotherapy",
									"Surgery",
									"No treatment"
								],
								"response_to_treatment_criteria_method": "RECIST 1.1",
								"response_to_treatment": "Partial remission",
								"chemotherapies": [],
								"hormone_therapies": [],
								"immunotherapies": [
									{
										"immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
										"drug_reference_database": "NCI Thesaurus",
										"immunotherapy_drug_dose_units": "IU/m2",
										"drug_name": "Gilteritinib",
										"drug_reference_identifier": "8756456",
										"prescribed_cumulative_drug_dose": 87,
										"actual_cumulative_drug_dose": 101
									}
								],

								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_23",
										"date_of_followup": "2022-09",
										"disease_status_at_followup": "Complete remission",
										"relapse_type": "Local recurrence and distant metastasis",
										"date_of_relapse": "2021-12",
										"method_of_progression_status": [],
										"anatomic_site_progression_or_recurrence": "C09",
										"recurrence_tumour_staging_system": "International Neuroblastoma Staging System",
										"recurrence_t_category": "Tis pd",
										"recurrence_n_category": "N3",
										"recurrence_m_category": "M1b",
										"recurrence_stage_group": "Stage IB1",
										"biomarkers": []
									}
								],
								"biomarkers": []
							}
						],
						"biomarkers": [],
						"followups": []
					}
				],
				"comorbidities": [
					{
						"prior_malignancy": "Unknown",
						"comorbidity_type_code": "C03.9",
						"comorbidity_treatment_status": "Yes",
						"comorbidity_treatment": "Bone marrow transplant",
						"age_at_comorbidity_diagnosis": 40
					}
				],
				"exposures": [],
				"biomarkers": [],
				"followups": []
			},
			{
				"submitter_donor_id": "DONOR_6",
				"program_id": "SYNTHETIC-2",
				"lost_to_followup_after_clinical_event_identifier": "",
				"lost_to_followup_reason": "Discharged to palliative care",
				"date_alive_after_lost_to_followup": "2022-08",
				"is_deceased": false,
				"cause_of_death": "Died of other reasons",
				"date_of_birth": "1972-12",
				"date_of_death": null,
				"gender": "Non-binary",
				"sex_at_birth": "Unknown",
				"primary_site": [
					"Hypopharynx",
					"Nasal cavity and middle ear",
					"Peripheral nerves and autonomic nervous system"
				],
				"primary_diagnoses": [
					{
						"submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_12",
						"date_of_diagnosis": "2019-06",
						"cancer_type_code": "C64.9",
						"basis_of_diagnosis": "Unknown",
						"lymph_nodes_examined_status": "Cannot be determined",
						"lymph_nodes_examined_method": "Imaging",
						"number_lymph_nodes_positive": 14,
						"clinical_tumour_staging_system": "AJCC 7th edition",
						"clinical_t_category": "T4b(s)",
						"clinical_n_category": "N1c",
						"clinical_m_category": "M1a",
						"clinical_stage_group": "Stage IC",
						"laterality": "Left",
						"specimens": [
							{
								"submitter_specimen_id": "SPECIMEN_18",
								"pathological_tumour_staging_system": "Binet staging system",
								"pathological_t_category": "T1a1",
								"pathological_n_category": "N3",
								"pathological_m_category": "M1c(1)",
								"pathological_stage_group": "In situ",
								"specimen_collection_date": "2020-01-07",
								"specimen_storage": "Unknown",
								"tumour_histological_type": "8620/9",
								"specimen_anatomic_location": "C43.9",
								"reference_pathology_confirmed_diagnosis": "Not done",
								"reference_pathology_confirmed_tumour_presence": "Yes",
								"tumour_grading_system": "Four-tier grading system",
								"tumour_grade": "High grade",
								"percent_tumour_cells_range": "51-100%",
								"percent_tumour_cells_measurement_method": "Unknown",
								"specimen_processing": "Cryopreservation - other",
								"specimen_laterality": "Right",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_24",
										"specimen_tissue_source": "Synovial fluid",
										"tumour_normal_designation": "Normal",
										"specimen_type": "Cell line - derived from metastatic tumour",
										"sample_type": "polyA+ RNA"
									}
								],
								"biomarkers": []
							}
						],
						"treatments": [
							{
								"submitter_treatment_id": "TREATMENT_18",
								"is_primary_treatment": "Yes",
								"treatment_start_date": "2021-09",
								"treatment_end_date": "2022-05",
								"treatment_setting": "Induction",
								"treatment_intent": "Preventive",
								"days_per_cycle": 5,
								"number_of_cycles": 4,
								"line_of_treatment": 3,
								"status_of_treatment": "Treatment stopped due to acute toxicity",
								"treatment_type": [
									"Photodynamic therapy",
									"No treatment",
									"Stem cell transplant"
								],
								"response_to_treatment_criteria_method": "Physician Assessed Response Criteria",
								"response_to_treatment": "Primary refractory disease",
								"chemotherapies": [],
								"hormone_therapies": [],
								"immunotherapies": [],
								"surgery": {
									"surgery_type": "Axillary lymph nodes sampling",
									"surgery_site": "C14",
									"surgery_location": "Primary",
									"tumour_focality": "Unifocal",
									"residual_tumour_classification": "R2",
									"margin_types_involved": [
										"Distal margin",
										"Circumferential resection margin"
									],
									"margin_types_not_involved": [],
									"margin_types_not_assessed": [
										"Unknown"
									],
									"lymphovascular_invasion": "Absent",
									"perineural_invasion": "Absent",
									"tumour_length": 9,
									"tumour_width": 7,
									"greatest_dimension_tumour": 5,
									"submitter_specimen_id": "SPECIMEN_18"
								},
								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_24",
										"date_of_followup": "2022-11",
										"disease_status_at_followup": "Progression not otherwise specified",
										"relapse_type": "Progression (liquid tumours)",
										"date_of_relapse": "2022-05",
										"method_of_progression_status": [
											"Imaging (procedure)"
										],
										"anatomic_site_progression_or_recurrence": "C13",
										"recurrence_tumour_staging_system": "Lugano staging system",
										"recurrence_t_category": "TX",
										"recurrence_n_category": "N0(mol-)",
										"recurrence_m_category": "M1d(0)",
										"recurrence_stage_group": "Stage IA1",
										"biomarkers": []
									}
								],
								"biomarkers": []
							}
						],
						"biomarkers": [],
						"followups": []
					}
				],
				"comorbidities": [
					{
						"prior_malignancy": "No",
						"comorbidity_type_code": "C02.1",
						"comorbidity_treatment_status": "Unknown",
						"comorbidity_treatment": "Ablation",
						"age_at_comorbidity_diagnosis": 51
					}
				],
				"exposures": [],
				"biomarkers": [],
				"followups": []
			},
			{
				"submitter_donor_id": "DONOR_7",
				"program_id": "SYNTHETIC-2",
				"lost_to_followup_after_clinical_event_identifier": "",
				"lost_to_followup_reason": "Lost contact",
				"date_alive_after_lost_to_followup": "2022-10",
				"is_deceased": false,
				"cause_of_death": "Unknown",
				"date_of_birth": "1961-05",
				"date_of_death": null,
				"gender": "Non-binary",
				"sex_at_birth": "Male",
				"primary_site": [
					"Floor of mouth"
				],
				"primary_diagnoses": [
					{
						"submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_13",
						"date_of_diagnosis": "2019-10",
						"cancer_type_code": "C02.2",
						"basis_of_diagnosis": "Death certificate only",
						"lymph_nodes_examined_status": "Yes",
						"lymph_nodes_examined_method": "Physical palpation of patient",
						"number_lymph_nodes_positive": 10,
						"clinical_tumour_staging_system": "Revised International staging system (RISS)",
						"clinical_t_category": "T2a1",
						"clinical_n_category": "N0b",
						"clinical_m_category": "M1c",
						"clinical_stage_group": "Stage IEA",
						"laterality": "Unilateral, side not specified",
						"specimens": [
							{
								"submitter_specimen_id": "SPECIMEN_19",
								"pathological_tumour_staging_system": "Rai staging system",
								"pathological_t_category": "T2a1",
								"pathological_n_category": "N3c",
								"pathological_m_category": "M1d(1)",
								"pathological_stage_group": "Stage IIIA",
								"specimen_collection_date": "2020-03-02",
								"specimen_storage": "Unknown",
								"tumour_histological_type": "8289/9",
								"specimen_anatomic_location": "C15.9",
								"reference_pathology_confirmed_diagnosis": "Not done",
								"reference_pathology_confirmed_tumour_presence": "Unknown",
								"tumour_grading_system": "FNCLCC grading system",
								"tumour_grade": "G1",
								"percent_tumour_cells_range": "0-19%",
								"percent_tumour_cells_measurement_method": "Genomics",
								"specimen_processing": "Cryopreservation - other",
								"specimen_laterality": "Not applicable",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_25",
										"specimen_tissue_source": "Pancreatic fluid",
										"tumour_normal_designation": "Normal",
										"specimen_type": "Metastatic tumour - metastasis to distant location",
										"sample_type": "Protein"
									}
								],
								"biomarkers": []
							}
						],
						"treatments": [
							{
								"submitter_treatment_id": "TREATMENT_19",
								"is_primary_treatment": "Yes",
								"treatment_start_date": "2021-07",
								"treatment_end_date": "2022-01",
								"treatment_setting": "Radiosensitization",
								"treatment_intent": "Diagnostic",
								"days_per_cycle": 4,
								"number_of_cycles": 4,
								"line_of_treatment": 5,
								"status_of_treatment": "Treatment completed as prescribed",
								"treatment_type": [
									"Stem cell transplant"
								],
								"response_to_treatment_criteria_method": "Cheson CLL 2012 Oncology Response Criteria",
								"response_to_treatment": "Complete remission without measurable residual disease (CR MRD-)",
								"chemotherapies": [],
								"hormone_therapies": [],
								"immunotherapies": [],
								"surgery": {
									"surgery_type": "Axillary Clearance",
									"surgery_site": "C14",
									"surgery_location": "Local recurrence",
									"tumour_focality": "Unknown",
									"residual_tumour_classification": "Unknown",
									"margin_types_involved": [],
									"margin_types_not_involved": [],
									"margin_types_not_assessed": [
										"Circumferential resection margin",
										"Proximal margin"
									],
									"lymphovascular_invasion": "Venous (large vessel) invasion only",
									"perineural_invasion": "Unknown",
									"tumour_length": 5,
									"tumour_width": 5,
									"greatest_dimension_tumour": 6,
									"submitter_specimen_id": null
								},
								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_25",
										"date_of_followup": "2022-11",
										"disease_status_at_followup": "Relapse or recurrence",
										"relapse_type": "Biochemical progression",
										"date_of_relapse": "2022-03",
										"method_of_progression_status": [
											"Physical examination procedure (procedure)"
										],
										"anatomic_site_progression_or_recurrence": "C15",
										"recurrence_tumour_staging_system": "AJCC 7th edition",
										"recurrence_t_category": "Tis(LAMN)",
										"recurrence_n_category": "N2a",
										"recurrence_m_category": "M1d(1)",
										"recurrence_stage_group": "Stage IIIA",
										"biomarkers": []
									}
								],
								"biomarkers": []
							}
						],
						"biomarkers": [],
						"followups": []
					}
				],
				"comorbidities": [
					{
						"prior_malignancy": "No",
						"comorbidity_type_code": "C67.6",
						"comorbidity_treatment_status": "Unknown",
						"comorbidity_treatment": "Radiation therapy",
						"age_at_comorbidity_diagnosis": 38
					}
				],
				"exposures": [
					{
						"tobacco_smoking_status": "Current reformed smoker, duration not specified",
						"tobacco_type": [
							"Unknown",
							"Electronic cigarettes",
							"Not applicable"
						],
						"pack_years_smoked": 104.0
					}
				],
				"biomarkers": [],
				"followups": []
			},
			{
				"submitter_donor_id": "DONOR_8",
				"program_id": "SYNTHETIC-2",
				"lost_to_followup_after_clinical_event_identifier": "",
				"lost_to_followup_reason": "Discharged to palliative care",
				"date_alive_after_lost_to_followup": "2022-03",
				"is_deceased": false,
				"cause_of_death": "Died of cancer",
				"date_of_birth": "2003-12",
				"date_of_death": null,
				"gender": "Woman",
				"sex_at_birth": "Unknown",
				"primary_site": [
					"Hypopharynx",
					"Thymus",
					"Esophagus",
					"Colon"
				],
				"primary_diagnoses": [
					{
						"submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_14",
						"date_of_diagnosis": "2019-07",
						"cancer_type_code": "C02.1",
						"basis_of_diagnosis": "Death certificate only",
						"lymph_nodes_examined_status": "No lymph nodes found in resected specimen",
						"lymph_nodes_examined_method": "Lymph node dissection/pathological exam",
						"number_lymph_nodes_positive": 13,
						"clinical_tumour_staging_system": "AJCC 6th edition",
						"clinical_t_category": "T2(s)",
						"clinical_n_category": "N1a",
						"clinical_m_category": "M0",
						"clinical_stage_group": "Regionalized",
						"laterality": "Left",
						"specimens": [
							{
								"submitter_specimen_id": "SPECIMEN_20",
								"pathological_tumour_staging_system": "Durie-Salmon staging system",
								"pathological_t_category": "T1b",
								"pathological_n_category": "N0(mol+)",
								"pathological_m_category": "M0(i+)",
								"pathological_stage_group": "Stage IIIB",
								"specimen_collection_date": "2021-02-23",
								"specimen_storage": "RNA later frozen",
								"tumour_histological_type": "8063/1",
								"specimen_anatomic_location": "C15.9",
								"reference_pathology_confirmed_diagnosis": "Not done",
								"reference_pathology_confirmed_tumour_presence": "Not done",
								"tumour_grading_system": "Grading system for GISTs",
								"tumour_grade": "Grade IV",
								"percent_tumour_cells_range": "0-19%",
								"percent_tumour_cells_measurement_method": "Image analysis",
								"specimen_processing": "Unknown",
								"specimen_laterality": "Not applicable",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_26",
										"specimen_tissue_source": "Bone marrow fluid",
										"tumour_normal_designation": "Normal",
										"specimen_type": "Recurrent tumour",
										"sample_type": "Total DNA"
									}
								],
								"biomarkers": []
							}
						],
						"treatments": [
							{
								"submitter_treatment_id": "TREATMENT_20",
								"is_primary_treatment": "Yes",
								"treatment_start_date": "2021-02",
								"treatment_end_date": "2022-09",
								"treatment_setting": "Locally advanced",
								"treatment_intent": "Diagnostic",
								"days_per_cycle": 4,
								"number_of_cycles": 5,
								"line_of_treatment": 1,
								"status_of_treatment": "Treatment stopped due to lack of efficacy (disease progression)",
								"treatment_type": [
									"Other targeting molecular therapy",
									"Photodynamic therapy",
									"Chemotherapy"
								],
								"response_to_treatment_criteria_method": "Physician Assessed Response Criteria",
								"response_to_treatment": "Minor response",
								"chemotherapies": [],
								"hormone_therapies": [],
								"immunotherapies": [],
								"surgery": {
									"surgery_type": "Tumor Debulking",
									"surgery_site": "C06",
									"surgery_location": "Primary",
									"tumour_focality": "Not applicable",
									"residual_tumour_classification": "RX",
									"margin_types_involved": [
										"Unknown",
										"Distal margin"
									],
									"margin_types_not_involved": [],
									"margin_types_not_assessed": [],
									"lymphovascular_invasion": "Venous (large vessel) invasion only",
									"perineural_invasion": "Present",
									"tumour_length": 3,
									"tumour_width": 6,
									"greatest_dimension_tumour": 5,
									"submitter_specimen_id": null
								},
								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_26",
										"date_of_followup": "2022-10",
										"disease_status_at_followup": "Distant progression",
										"relapse_type": "Local recurrence",
										"date_of_relapse": "2022-10",
										"method_of_progression_status": [
											"Physical examination procedure (procedure)",
											"Assessment of symptom control (procedure)"
										],
										"anatomic_site_progression_or_recurrence": "C06",
										"recurrence_tumour_staging_system": "International Neuroblastoma Risk Group Staging System",
										"recurrence_t_category": "T2(s)",
										"recurrence_n_category": "N3c",
										"recurrence_m_category": "M1c",
										"recurrence_stage_group": "Stage IIIS",
										"biomarkers": []
									}
								],
								"biomarkers": []
							}
						],
						"biomarkers": [],
						"followups": []
					}
				],
				"comorbidities": [
					{
						"prior_malignancy": "Yes",
						"laterality_of_prior_malignancy": "Unknown",
						"comorbidity_type_code": "C64.9",
						"comorbidity_treatment_status": "Yes",
						"comorbidity_treatment": "Surgery",
						"age_at_comorbidity_diagnosis": 51
					}
				],
				"exposures": [
					{
						"tobacco_smoking_status": "Current reformed smoker for > 15 years",
						"tobacco_type": [
							"Waterpipe",
							"Unknown"
						],
						"pack_years_smoked": 48.0
					}
				],
				"biomarkers": [],
				"followups": []
			},
			{
				"submitter_donor_id": "DONOR_9",
				"program_id": "SYNTHETIC-2",
				"lost_to_followup_after_clinical_event_identifier": "",
				"lost_to_followup_reason": "Withdrew from study",
				"date_alive_after_lost_to_followup": "2022-05",
				"is_deceased": false,
				"cause_of_death": "Died of other reasons",
				"date_of_birth": "1993-10",
				"date_of_death": null,
				"gender": "Woman",
				"sex_at_birth": "Female",
				"primary_site": [
					"Trachea",
					"Other and ill-defined digestive organs"
				],
				"primary_diagnoses": [
					{
						"submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_15",
						"date_of_diagnosis": "2019-01",
						"cancer_type_code": "C05.1",
						"basis_of_diagnosis": "Specific tumour markers",
						"lymph_nodes_examined_status": "Yes",
						"lymph_nodes_examined_method": "Physical palpation of patient",
						"number_lymph_nodes_positive": 15,
						"clinical_tumour_staging_system": "International Neuroblastoma Staging System",
						"clinical_t_category": "T3(s)",
						"clinical_n_category": "N1b",
						"clinical_m_category": "M1c(0)",
						"clinical_stage_group": "Stage IIA",
						"laterality": "Unilateral, side not specified",
						"specimens": [
							{
								"submitter_specimen_id": "SPECIMEN_21",
								"pathological_tumour_staging_system": "Durie-Salmon staging system",
								"pathological_t_category": "Tis(DCIS)",
								"pathological_n_category": "N2",
								"pathological_m_category": "M1d(0)",
								"pathological_stage_group": "Stage IIS",
								"specimen_collection_date": "2020-12-07",
								"specimen_storage": "Not Applicable",
								"tumour_histological_type": "8630/9",
								"specimen_anatomic_location": "C43.9",
								"reference_pathology_confirmed_diagnosis": "Unknown",
								"reference_pathology_confirmed_tumour_presence": "Not done",
								"tumour_grading_system": "Four-tier grading system",
								"tumour_grade": "High grade",
								"percent_tumour_cells_range": "51-100%",
								"percent_tumour_cells_measurement_method": "Unknown",
								"specimen_processing": "Cryopreservation - other",
								"specimen_laterality": "Left",
								"sample_registrations": [
									{
										"submitter_sample_id": "SAMPLE_REGISTRATION_27",
										"specimen_tissue_source": "Blood derived - peripheral blood",
										"tumour_normal_designation": "Normal",
										"specimen_type": "Normal",
										"sample_type": "Protein"
									}
								],
								"biomarkers": []
							}
						],
						"treatments": [
							{
								"submitter_treatment_id": "TREATMENT_21",
								"is_primary_treatment": "Unknown",
								"treatment_start_date": "2021-03",
								"treatment_end_date": "2022-10",
								"treatment_setting": "Locally advanced",
								"treatment_intent": "Forensic",
								"days_per_cycle": 3,
								"number_of_cycles": 3,
								"line_of_treatment": 4,
								"status_of_treatment": "Other",
								"treatment_type": [
									"Photodynamic therapy"
								],
								"response_to_treatment_criteria_method": "Response Assessment in Neuro-Oncology (RANO)",
								"response_to_treatment": "Progressive disease",
								"chemotherapies": [],
								"hormone_therapies": [],
								"immunotherapies": [],
								"surgery": {
									"surgery_type": "Pancreaticojejunostomy, side-to-side anastomosis",
									"surgery_site": "C12",
									"surgery_location": "Metastatic",
									"tumour_focality": "Unknown",
									"residual_tumour_classification": "R0",
									"margin_types_involved": [],
									"margin_types_not_involved": [
										"Unknown"
									],
									"margin_types_not_assessed": [],
									"lymphovascular_invasion": "Venous (large vessel) invasion only",
									"perineural_invasion": "Present",
									"tumour_length": 6,
									"tumour_width": 6,
									"greatest_dimension_tumour": 6,
									"submitter_specimen_id": null
								},
								"followups": [
									{
										"submitter_follow_up_id": "FOLLOW_UP_27",
										"date_of_followup": "2022-08",
										"disease_status_at_followup": "Stable",
										"relapse_type": "Distant recurrence/metastasis",
										"date_of_relapse": "2022-06",
										"method_of_progression_status": [
											"Laboratory data interpretation (procedure)",
											"Histopathology test (procedure)"
										],
										"anatomic_site_progression_or_recurrence": "C08",
										"recurrence_tumour_staging_system": "International Neuroblastoma Staging System",
										"recurrence_t_category": "T3b",
										"recurrence_n_category": "N0(i-)",
										"recurrence_m_category": "M1c(0)",
										"recurrence_stage_group": "Stage 0",
										"biomarkers": []
									}
								],
								"biomarkers": []
							}
						],
						"biomarkers": [],
						"followups": []
					}
				],
				"comorbidities": [],
				"exposures": [],
				"biomarkers": [],
				"followups": []
			}
	]
}